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OUTCOMES OF UNILATERAL ALVEOLAR CLEFTS GRAFTED USING
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2: A
RETROSPECTIVE VOLUMETRIC ANALYSIS USING CBCT
Landon R. Peterson, M.S.
University of Nebraska, 2020

Advisor: Sundaralingam Premaraj, B.D.S., M.S., Ph.D., FRCD(C)
Purpose of this study is to evaluate the success rates of secondary alveolar grafts using recombinant
human bone morphogenetic protein with CBCT and to evaluate the effects of several variables on
these outcomes. After our inclusion/exclusion criteria, records of 24 patients receiving secondary
alveolar grafts at the University of Nebraska Medical Center were evaluated. Pre-graft and 6-month
post-graft cleft volumes were measured using ITK-SNAP 3.8.0 software to determine a percent
residual defect following surgery. Of the 24 patients, one was excluded as the graft surgery was
deemed a failure. The patients’ gender, age, side of cleft, cleft side canine root lengths, angulations,
and distance from the occlusal plane were also measured. The mean volumetric values for the pregraft and post-graft clefts were 1049.30mm3 and 413.75mm3, respectively with a mean residual
defect value of 0.32 (SD = 0.22). The difference in percent residual defect following the graft was
not statistically significant for any of the variables measured, except for gender (F=10.63; DF=1,21;
p=0.0037). This study showed females undergoing secondary grafts of unilateral alveolar clefts
have a lower percent residual defect six months following surgery. However, the results of this
study may not represent clinical outcomes and larger sample sizes may be helpful to conclude
statistically significant differences between our variables.

iii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS...............................................................................................................i
ABSTRACT.....................................................................................................................................ii
TABLE OF CONTENTS................................................................................................................iii
LIST OF FIGURES.........................................................................................................................vi
LIST OF TABLES.........................................................................................................................viii
CHAPTER 1: INTRODUCTION.....................................................................................................1
CHAPTER 2: LITERATURE REVIEW..........................................................................................5
2.1. Cleft Lip and Cleft Palate ……………………..…......................................................5
2.1.1. Etiology…………………………………………………………………….5
2.1.2. Biological Considerations…………………………………………………6.
2.1.3. Associated Syndromes………………………………………………….….7
2.1.4. Classification…………………………………………………………..…..9
2.1.5. Prevalence…………………………………………………………..…….10
2.2. Alveolar Cleft…………………………………………………………………….….11
2.3. Managing Alveolar Clefts….......................................................................................12
2.3.1. History……………………………………………………………………12
2.3.2. Goals……………………………………………………………………...13
2.3.3. Treatment Timing………………………………………….......................13
2.3.4. Outcomes and Success Rates……………………......................................14
2.4. Materials Used for Secondary Alveolar Grafts…………….……………..................17
2.5. Cone Beam Computed Tomography to Evaluate Alveolar Graft Procedures………21
CHAPTER 3: RESEARCH HYPOTHESIS & SPECIFIC AIMS ….............................................23
3.1. Statement of the Problem…........................................................................................23

iv
3.2. Central Research Hypothesis ….................................................................................24
3.3. Specific Aims…..........................................................................................................24
CHAPTER 4: MATERIALS & METHODS…..............................................................................25
4.1. Study Design…...........................................................................................................25
4.1.1. Data Collection….......................................................................................25
4.1.2. Surgical Technique…………………………………………………….…26
4.2. Linear Measurements…..............................................................................................27
4.3. Volumetric Measurements…......................................................................................29
4.4. Statistical Analysis…..................................................................................................31
4.5. Intra-examiner and Inter-examiner Reliability….......................................................32
CHAPTER 5: RESULTS…............................................................................................................49
5.1. Subjects…...................................................................................................................49
5.2. Demographic Variables and Their Effects on Outcomes…………………………...49
5.2.1. Gender…………………………………………………………………….49
5.2.2. Age of the Patient at the Time of Grafting ………………………………50
5.2.3. Side of the Alveolar Cleft ………………….…………………………….50
5.3. Linear Values and Their Effects on Outcomes……………………………………...51
5.3.1. Cleft Side Canine Root Length…………………………………………...51
5.3.2. Cleft Side Canine Angulation; Coronal Section………………………….51
5.3.3. Cleft Side Canine Angulation; Sagittal Section…………………………..52
5.3.4 Cleft Side Canine Distance from the Occlusal Plane……………………..53
5.4. Volumetric Values and Percent Residual Defect……………….…………………...53
5.5. Intra-examiner and Inter-examiner Reliability….......................................................54

v
CHAPTER 6: DISCUSSION…......................................................................................................80
6.1. Demographic Variables and Their Effects on Outcomes…………………………...80
6.1.1. Gender…………………………………………………………………….80
6.1.2. Age of the Patient at the Time of Grafting……………………………….80
6.1.3. Side of the Alveolar Cleft………………………………………………...81
6.2. Linear Values and Their Effects on Outcomes……………………………………...81
6.2.1. Cleft Side Canine Root Length…………………………………………...81
6.2.2. Cleft Side Canine Angulation; Coronal and Sagittal Sections…………...82
6.2.3. Cleft Side Canine Distance from the Occlusal Plane…………………….83
6.3. Volumetric Values and Percent Residual Defect……………………………………84
6.4. Limitations of the Study…………………………………………….. ……………...85
6.4.1. Radiographic Limitations………………………………………………...85
6.4.2. Software Limitations……………………………………………………..86
6.4.3. Sample Limitations……………………………………………………….87
6.5. Conclusions………………………………………………………………………….87
6.6. Future Research……………………………………………………………………..88
BIBLIOGRAPHY….......................................................................................................................90

vi

LIST OF FIGURES
Figure 1.1. Unilateral Alveolar Cleft…………………....................................................................4
Figure 2.1.1. Normal Embryologic Development…………………..…........................................33
Figure 2.1.4. Kernahan Striped “Y” Classification System…........................................................34
Figure 2.2.1. Alveolar Cleft Shape……………..….......................................................................35
Figure 2.5.1. Bergland Scale……………………………………………………………………...36
Figure 2.5.2. Chelsea Scale……………………………………………………………………….37
Figure 4.2.1. Cleft Side Canine Root Length Measurement….......................................................38
Figure 4.2.2. Cleft Side Canine Angulation; Coronal Section……………………………………39
Figure 4.2.3. Cleft Side Canine Angulation; Sagittal Section……………………………………40
Figure 4.3.1. Region of Interest for Semi-automatic Mode............................................................41
Figure 4.3.2. Active Contour Evolution Parameters in ITK-SNAP 3.8.0…..................................42
Figure 4.3.3. Pre-set Bubbles in the Initialization Mode…………………….…...........................43
Figure 4.3.4. Auto-segmentation of Bone and/or Hard Tissues………………….........................44
Figure 4.3.5. Polygon Mode; Manual Segmentation of the Cleft…...............................................45
Figure 4.3.6. Final Volumetric Segmentation Image in ITK-SNAP 3.8.0….................................47
Figure 4.3.7. Final Volumetric Measurement in ITK-SNAP 3.8.0………………………… ........48
Figure 5.2.1.1. Box & Whisker Plot for Male/Female……………………………………………56
Figure 5.2.1.2. Least Squares Means Plot for Male/Female……………………………………...58
Figure 5.2.2.1. Scatter Plot – Age of Patient at Time of Grafting……………..............................59
Figure 5.2.3.1. Box & Whisker Plot for Left/Right Side Alveolar Cleft…………………………61
Figure 5.2.3.2. Least Squares Means Plot for Left/Right Side Alveolar Cleft…………………...63
Figure 5.3.1.1. Scatter Plot – Cleft Side Canine Root Length……………………………………64
Figure 5.3.2.1. Scatter Plot – Cleft Side Canine Angulation (Coronal)…………………………..66
Figure 5.3.3.1. Scatter Plot – Cleft Side Canine Angulation (Sagittal)…………………………..68

vii
Figure 5.3.4.1. Scatter Plot – Cleft Side Canine Distance from Occlusal Plane………………….70
Figure 5.4.1. Overall Volumetric Values for Unilateral Clefts…………………………………...72
Figure 5.4.2. Percent Residual Defect Using rhBMP-2…………………………………………..73
Figure 5.4.3. Percent Residual Defect Using rhBMP-2; Male/Female…………………………...74
Figure 5.4.4. Percent Residual Defect Using rhBMP-2; Left/Right Alveolar Cleft……………...75

viii

LIST OF TABLES
Table 4.3.1. Region of Interest Boundaries for Manual Segmentation ……..................................46
Table 5.2.1.1. Type III Tests for Fixed Effects – Male/Female…………………………………..57
Table 5.2.1.2. Least Squares Means – Male/Female……………………………………………..57
Table 5.2.2.1. Type I Tests of Fixed Effects - Age……………………………………………….60
Table 5.2.2.2. Regression Coefficient Estimates for Age of the Patient………………………….60
Table 5.2.3.1. Type III Tests for Fixed Effects – Left/Right Side Alveolar Cleft………………..62
Table 5.2.3.2. Least Squares Means – Left/Right Side Alveolar Cleft…………………………...62
Table 5.3.1.1. Type I Tests of Fixed Effects – Cleft Side Canine Root Length………………….65
Table 5.3.1.2. Regression Coefficient Estimates for Cleft Side Canine Root Length…………....65
Table 5.3.2.1. Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Coronal)………...67
Table 5.3.2.2. Regression Coefficient Estimates for Cleft Side Canine Angulation (Coronal)…..67
Table 5.3.3.1. Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Sagittal)………...69
Table 5.3.3.2. Regression Coefficient Estimates for Cleft Side Canine Angulation (Sagittal)…..69
Table 5.3.4.1. Type I Tests of Fixed Effects – Cleft Side Canine Distance from Occlusal
Plane……………………………………………………………………………………...71
Table 5.3.4.2. Regression Coefficient Estimates for Cleft Side Canine Distance from Occlusal
Plane……………………………………………………………………………………...71
Table 5.4.1. Overall Volumetric Values for Unilateral Clefts……………………………………72
Table 5.4.2. Percent Residual Defect Using rhBMP-2…………………………………………...73
Table 5.5.1. Inter-examiner Reliability Raw Data……………………………………………......76
Table 5.5.2. Inter-examiner ICC3 Results………………………………………………………..76
Table 5.5.3. Intra-examiner ICC3 Results for Cleft Volume; Investigator LP……………….….77
Table 5.5.4. Intra-examiner ICC3 Results for Cleft Volume; Investigator SP………………...…77

ix
Table 5.5.5. Inter-examiner ICC3 Results for Cleft Side Canine Length………………………...77
Table 5.5.6. Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator LP………78
Table 5.5.7. Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator SP………78
Table 5.5.8. Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Coronal);
Investigator LP…………………………………………………………………………..78
Table 5.5.9. Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Sagittal);
Investigator LP…………………………………………………………………………..79
Table 5.5.10. Intra-examiner ICC3 Results for Cleft Side Canine Distance from Occlusal Plane;
Investigator LP…………………………………………………………………………..79

1

CHAPTER 1: INTRODUCTION
Birth defects are always a concern for parents and may cause lifelong setbacks, especially
in the early part of the child’s life. In the United States, 7,500 children are born every year with
orofacial clefts, and the lifetime medical cost per child with orofacial clefts is significant,
averaging $100,000 (Tolarová and Cervenka 1998). Worldwide, cleft lip and palate are among
the most common birth defects that occur. These can occur as isolated conditions or they can be a
component of a syndrome or inherited disease. The prevalence of cleft palate is 1 per 1,574 live
births. The prevalence of cleft lip, with or without cleft palate, is 1 per 940 live births (Parker et
al. 2010). Within this group of patients born with cleft lip and palate, approximately 75% have
maxillary alveolar clefts (Bell et al. 1980).
According to Kang, an alveolar cleft is “a tornado-shaped bone defect in the maxillary
arch” (2017). Alveolar clefts cause a disruption to the normal continuous bony environment in the
maxillary arch. This can lead to multiple factors that affect the child and child’s parents
including: early feeding difficulties, nutritional issues, developmental delays, speech difficulties,
facial asymmetry, hearing loss, discomfort during and/or following surgical procedures, time
commitments, the need for orthodontic care, and possibly psychosocial issues for the child and/or
child’s parents (Coots 2012).
Bone grafting of alveolar clefts has become an essential component in the contemporary
management of patients with orofacial clefts. Secondary alveolar bone grafting has been shown to
improve some of the factors listed above as well as allow for successful orthodontic treatment and
implant or prosthetic rehabilitation (Cho-Lee et al. 2013).
Up until about the past 10 years, anterior iliac crest (AIC) autogenic bone has been
considered the gold standard grafting material for alveolar clefts. AIC’s regeneration potential
and high success rates make it a viable option for these children (Kazemi et al. 2002). However,
there are several shortcomings with using iliac crest including: significant post-operative
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morbidity, hematomas, pain, delayed ambulation, and prolonged hospitalization (Baqain et al.
2009). To overcome these shortcomings, there have been attempts to find a viable replacement
material to use in secondary alveolar grafts. Recombinant human bone morphogenetic protein 2
(rhBMP-2) was approved by the Food and Drug Administration for maxillary sinus augmentation
in 2004 and ridge augmentation following dental extractions in 2007. This material has since
been shown to be a successful alternative when reconstructing an alveolar cleft (Francis et al.
2013; van Hout et al. 2011).
The proper timing for reconstructing alveolar clefts is still slightly controversial.
Secondary alveolar bone grafting, undertaken late in mixed dentition before eruption of the
canine, is currently considered the standard treatment (Francis et al. 2013). There are also a
number of other variables that are believed to influence the outcome of alveolar bone grafts
including: chronological age of the patient at the time of the graft, stage of root development for
the cleft side canine at the time of the graft, the surgeon who performed the graft, and unilateral
versus bilateral clefts (Francis et al. 2013; Oberoi et al. 2009; Seifeldin 2016). The way in which
we view several of these variables has changed over time.
Occlusal and periapical radiographs have been used to evaluate bone fill within these
alveolar clefts and to map segmentally the height, thickness, and position of bone on the roots
adjacent to the cleft. Hammoudeh et al. reported the results of comparing rhBMP-2 with a
demineralized bone matrix versus iliac crest bone for secondary alveolar bone graft using
occlusal radiographs (2017). There are obvious shortcomings in attempting to determine the
outcomes of alveolar bone grafts from 2-dimensional images. With the advent of 3-demensional
imaging systems such as cone beam computed tomography (CBCT), a more accurate analysis can
be performed when studying alveolar bone graft outcomes. Thus, CBCT has become the new
standard for analyzing bone fill of alveolar clefts.
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The rationale for this project is that its successful completion would help to determine
the effects of several variables on the proper timing of secondary alveolar graft procedures and on
the success rates for these procedures. CBCT analysis of maxillary alveolar clefts allow for
assessing the bone defect in three dimensions, a shortcoming of previous conventional
radiographic studies. This research is potentially innovative because our specific variables and
their effects on unilateral alveolar cleft grafting success rates have yet to be explored with 3dimensional software in regards to these treatment differences. The primary impact of our
anticipated findings would be determining the overall success rates of secondary alveolar grafting
procedures using rhBMP-2 as an alternative material and understanding specific variables that
may allow craniofacial and cleft teams to better manage patients with orofacial clefts.
The purpose of this study is to evaluate the success rates of secondary alveolar grafts
using rhBMP-2 as a grafting material with 3-dimensional CBCT as well as to evaluate the effects
of several variables on these outcomes.
The null hypothesis is there will be no difference in secondary alveolar graft success
rates when comparing our specific variables and their effects on these outcomes using 3dimensional software for analysis.
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Figure 1.1.: Unilateral Alveolar Cleft. Example of a unilateral alveolar cleft is shown. A)
Diagram showing a unilateral (left) alveolar cleft with tissue intact. B) A mucoperiosteal flap has
been reflected to show the underlying bone defect and unerupted upper left permanent canine. Note
that this unerupted canine has 2/3’s of its root developed. Graphics by K. Theesen. Additional credit
to Dias et al. 2018.
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CHAPTER 2: LITERATURE REVIEW
2.1. Cleft Lip and Cleft Palate
2.1.1. Etiology
Development of cleft lip and cleft palate (CLCP) happens early in embryologic
development. Between the fourth and eighth week of embryologic life, the embryo undergoes
rapid changes in shape and growth as the six branchial arches are formed. The first two branchial
arches are responsible for the development of the face and the cranium. The face begins to
develop from the ectomesenchyme, derived from neural crest cells, which forms five
prominences. These prominences include the frontonasal process and two maxillary and two
mandibular processes (one of each per side) surrounding a central depression (Sperber et al.
2001).
The primary and secondary palates are derived from the medial nasal and maxillary
processes and are two of the main structures involved with the formation of orofacial clefts. Rani
et al. defines the primary palate as comprising the premaxilla, anterior septum, and upper lip. The
roof of the mouth extends from the incisive foramen or its vestige, the incisive papilla, to the
uvula. This area is termed the secondary palate. The incisive foramen is the dividing line
between the primary and secondary palates (2011).
Clefting of the lip occurs in response to a failure of fusion between the medial nasal
process, which is an extension of the frontonasal process, and the maxillary prominence. The
fusion of these prominences normally occurs during the sixth week of embryologic development.
The normal fusion of these structures during primary palate formation creates not only the upper
lip but also the area of the alveolar ridge containing the central and lateral incisors. Since there is
a disruption in the normal development of this area, a cleft in the alveolar process will often
accompany a cleft lip (Proffit et al. 2013).

6
Clefting of the palate occurs in response to a slightly different abnormality. Closure of
the secondary palate by elevation of the palatal shelves follows the formation of the primary
palate by nearly two weeks; around the eighth week of embryologic life. There is a disruption in
this normal fusion of the palatal shelves, which leads to a palatal cleft. An interference with
normal lip closure that is still present at this time can also affect the proper development of the
secondary palate. About 60% of subjects with cleft lip also have cleft palate (Proffit et al. 2013).
Additionally, 75% of individuals born with cleft lip and palate have maxillary alveolar clefts
(Bell et al. 1980).
Normal embryologic development (Figure 2.1.1) of other facial structures is also a result
of proper fusion of prominences derived from the first two branchial arches. For example, the
mandibular processes fuse to form the lower lip and jaw and the lateral nasal processes form the
alar structure of the nose bilaterally (Sperber et al. 2001).

2.1.2. Biological Considerations
As the neural crest cells migrate and proliferate to their respective branchial arches, they
interact with extracellular matrix and adjacent epithelia, which partly determines the patterning
and nature of the derivative tissues they will form. These include neural, skeletal, connective, and
muscular tissues (Sarkar et al. 2001).
The development of facial structures is the result of cell proliferation, differentiation,
adhesion, and apoptosis. The facial prominences of the neural crest cells are controlled by
molecular signals. These signals are a result of interactions and responses to genes that include
the transforming growth factor beta (TGF-b) super family, sonic hedgehog (SHH), fibroblast
growth factors (FGFs), and bone morphogenic proteins (BMPs). Orofacial clefts are a result of
failures or errors in any of these intracellular mechanisms that disrupt the normal fusion or
development of facial prominences (Marazita and Mooney 2004).
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In addition to the genes listed previously, there are a number of other genes that have
been linked to orofacial cleft development. The homeobox (Hoxa-1, Hoxa-2, Hoxb-1, Hoxb-3,
Hoxb-4), OXT (orthodontical), GSC (goosecoid), DLX (distalless), and MSX (muscle segment)
gene families have also been expressed in the ectomesenchyme derived from the neural crest.
Many of these genes are candidates for causing orofacial clefting (Sperber et al. 2001).
There are also environmental factors that contribute to the development of orofacial
clefts. These factors can be divided into four groups: drugs, chemicals, maternal metabolic
imbalances (folic acid deficiency), and maternal infections. Maternal consumption of alcohol and
teratogenic medications such as retinoids, corticosteroids, and anti-convulsants during the
periconceptional period can cause facial abnormalities including orofacial clefts (Eppley et al.
2005). Genetic mutations and environmental impacts upon the complex mechanisms of
craniofacial development lead to phenotypic anomalies, of which orofacial clefting is the most
common (Schutte and Murray 1999).
Many mechanisms underlying normal and abnormal embryogenesis of the craniofacial
structures are well understood. The genetic factors that cause abnormal development and result in
orofacial clefts are not completely clear, however much progress has been accomplished over the
years. The emerging consensus is that the genetic etiology of nonsyndromic clefting is complex,
with several loci showing drastic results in at least some studies. In addition, genes or
chromosomal rearrangements on many chromosomes can lead to syndromes that include
orofacial clefts (Marazita and Mooney 2004).

2.1.3. Associated Syndromes
As we have learned, orofacial clefts can have an environmental or genetic origin
depending on how the abnormality was caused. Although the nonsyndromic clefts are more
common and likely due to secondary gene-environment interactions, orofacial clefts can occur as
one component of multiple congenital anomaly syndromes (Schutte and Murray 1999).
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Every structural abnormality in the body that is congenital represents an embryologic
error in morphogenesis and may affect one or more systems (Venkatesh 2009). There are
currently over 400 known syndromes either directly or indirectly associated with cleft lip and/or
cleft palate. It has been estimated that approximately three percent of all orofacial cleft cases are
related to known syndromes (Fraser 1970).
Van der Woude syndrome is one of the most common syndromes associated with
orofacial clefts. This syndrome is autosomal dominant and can display several other features
including: hypodontia, missing maxillary or mandibular second premolar teeth, absent maxillary
lateral incisor, ankyloglosia, and the hallmark feature of lower lip pits (Venkatesh 2009).
Another autosomal dominant disorder that is associated with orofacial clefts is Treacher
Collins syndrome. This syndrome results from the loss-of-function mutation in the TCOF-1 gene.
This gene encodes for the phosphoprotein “treacle” and can affect craniofacial development.
Treacher Collins syndrome affects the size and shape of the ears, cheekbones, and jaw. Some of
the key features include: downslanting eyes, underdeveloped cheek and jaw bones, notched lower
eyelids, and cleft palate (Dixon et al. 2000).
Pierre Robin sequence is another congenital condition that is associated with cleft lip
and/or cleft palate. In 1926, Pierre Robin published a case with a triad of glossoptosis,
micrognathia, and airway obstruction. Although cleft palate was not included in this triad, they
are frequently associated with this sequence. The most accepted theory involves the initial event
of mandibular hypoplasia, which keeps the tongue elevated in the oral cavity. This prevents
fusion of the palatal shelves resulting in cleft palate (Venkatesh 2009).
Velocardiofacial syndrome is another autosomal dominant condition that is associated
with orofacial clefts. This syndrome is a result of a sub-microscopic deletion on the long arm of
chromosome 22 in the “q11” region. It was first described by Dr. Robert Shprintzen and affects
every major system in the body. Some of the more common features include: cleft palate, minor
learning problems, speech issues, feeding problems, and cardiac anomalies (Venkatesh 2009)
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Stickler syndrome is a connective tissue disorder that is also associated with cleft palate.
It is also an autosomal dominant disorder with ophthalmological and orofacial features. Stickler
syndrome is a result of a mutation in the COL2A1 gene and children with this condition can
display midline clefting ranging in severity from a cleft of the soft palate to complete cleft lip and
palate. Other features of this syndrome include: a flat midface with depressed nasal bridge, short
nose, anteverted nares, and micrognathia (Snead and Yates 1999).
Understanding the etiology of orofacial clefts is vital for proper prevention, treatment,
and management. Appropriate genetic testing, diagnosis, and treatment planning of orofacial
clefts by a craniofacial cleft lip/cleft palate team can provide comfort to the patient and patient’s
parents. This can also lead to proper management and give the team the highest chance for a
successful treatment outcome.

2.1.4 Classification
There are about one hundred different combinations of cleft lip and cleft palate. Having a
system in place to properly diagnose the clefts and determine a severity assessment helps in the
planning of an appropriate treatment method. An ideal system would be easy to understand, easy
to locate and to quantify the cleft lesion, easy to document, easily applicable to computerized data
analysis, and should be applicable for both clinical applications and research (Rani and
Chickmagalur 2011).
Classification of cleft lip and cleft palate deformities has been through multiple changes
over the years, each with a different basis for classifying these orofacial clefts, ranging from
anatomic and embryologic considerations to the complexity of the deformity. Davis and Ritchie
developed one of the first classification systems in 1922, which was used for years, despite its
shortcomings. To date, the Kernahan and Stark’s classification system and Kernahan’s modified
“striped Y” diagram (Figure 2.1.4) is one of the most widely used systems worldwide (Rani and
Chickmagalur 2011).
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Although classifying cleft lip and cleft palate has cycled through systems relating to the
morphological and embryological backgrounds, schemes for classifying cleft lip and/or cleft
palate are usually anatomically based. These classifications may include complete or incomplete,
unilateral or bilateral, a submucous cleft, and/or bifid uvula (Seifeldin 2016).

2.1.5. Prevalence
Cleft lip and/or cleft palate is the most prevalent congenital craniofacial birth defect. The
incidence ratio for cleft lip and/or cleft palate has been reported to be approximately 1:700 live
births (Cobourne 2004). Additionally, cleft lip and/or cleft palate is the second most common
congenital malformation following clubfoot (Miloro et al. 2004). The occurrence of cleft palate is
6.35 per 10,000 live births. The occurrence of cleft lip, with or without cleft palate, is 10.63 per
10,000 live births (Parker et al. 2010). Within this group of patients born with cleft lip and palate,
approximately 75% have maxillary alveolar clefts (Bell et al. 1980).
Unilateral cleft lip and palate is more common than bilateral. Cleft lip and palate is more
common on the left side than on the right side. When cleft palate is analyzed alone, it is more
common in females and most often associated with other developmental anomalies (Seifeldin
2016). However, if analyzing cleft lip, alveolus, and palate, males are more often affected than
females (van Hout et al. 2011).
The incidence of these clefts (alveolus, palate, and lip) also varies between different
races. Mongolians have an incidence of 0.55-2.5 per 1,000 births. Caucasians have an incidence
of 0.69-2.35 per 1,000 births. And finally, Negroids have an incidence of 0.18-0.82 per 1,000
births (van Hout et al. 2011).
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2.2. Alveolar Cleft
The term alveolus is of Latin origin and refers to a small cavity (Coots 2012). The
alveolus is a part of the primary palate and is formed by the fusion of the maxillary prominences
approximately at the fifth and sixth weeks of intrauterine development. The primary palate gives
rise to structures including: nose, lip, prolabium, and the premaxilla; all of which are anterior to
the incisive foramen (van Aalst et al. 2008). The incisive foramen has been determined to be the
dividing structure differentiating the primary and secondary palates.
The alveolar processes, found in both the maxilla and mandible, are where the tooth
sockets are located. These alveolar processes, and the bone that makes them up, are connected to
the teeth via periodontal ligaments. In individuals with alveolar clefts, the individual’s permanent
teeth, which are above the alveolar cleft, are not sustainable if there is not adequate bone stock
placed in the alveolar cleft into which they can erupt. The permanent maxillary canine tooth
typically erupts into the alveolar cleft space or becomes impacted. The permanent maxillary
lateral incisor tooth erupts either adjacent to the alveolar cleft or into the cleft (Coots 2012).
According to Kang, an alveolar cleft is “a tornado-shaped bone defect in the maxillary
arch.” Alveolar clefts occur in response to divergence from normal intrauterine development
during frontonasal prominence growth, contact, and fusion. Although maxillary alveolar clefts
can occur mesial to either the lateral incisor or canine, the most common location is between the
lateral incisor and canine (2017). These three dimensional defects are pyramidal in shape (Figure
2.2.1) with the following boundaries: nasal floor superiorly, posterior alveolus (palate) inferiorly,
anterior alveolus anteriorly, and medial/lateral cleft margins determining the medial and lateral
borders (Craven et al. 2007).
Alveolar clefts cause a disruption in the continuity of the maxillary arch. This can lead to:
early feeding difficulties, nutritional issues, developmental delays, speech difficulties, facial
asymmetry, hearing loss, discomfort during and/or following surgical procedures, time
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commitments, delayed or ectopic eruption patterns, the need for orthodontic care, and possibly
psychosocial issues for the child and/or child’s parents (Coots 2012).

2.3. Managing Alveolar Clefts
2.3.1. History
Reconstruction of alveolar cleft is believed to be introduced by von Eiselsberg in the
early 20th century. He used autologous tissue to assist with the reconstruction process. Lexer was
the first to describe a nonvascular bone graft. Drachter reported the repair of an alveolar cleft
using the tibial bone as a grafting material, while Schmid was the first to utilize this procedure for
implanting iliac bone grafts into the defect. Skoog developed a boneless bone graft technique
known as gingivoperiosteoplasty (Kang 2017).
Up until the 1970’s, “primary bone grafting” was completed while the individual with
alveolar cleft was an infant. This was accomplished with rib bone and was the popular surgical
procedure used to manage alveolar clefts (Kang 2017). Primary bone grafting involves
reconstruction of the alveolar cleft in association with soft tissue repair to the cleft lip. This
technique gained popularity because it simultaneously addressed both soft tissue and bony deficit
repair. It also was thought this technique would allow for harmonious facial growth and
development following the procedure (Seifeldin 2016).
However, there were shortcomings associated with primary alveolar bone grafting.
Robertson and Rherm reported adverse developmental effects on maxillary development.
Individuals who had primary bone grafting were seen to have midface retrusion and/or anterior
cross bites (Dissaux et al. 2016). This led to the currently accepted approach of “secondary bone
grafting.”
Secondary bone grafting is the most recognized surgical approach for managing alveolar
defects in cleft lip/cleft palate individuals. It is believed that the shortcomings associated with
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primary bone grafts are not as serious of a concern when the procedure is completed later in
development (Kang 2017).

2.3.2. Goals
Every individual born with a cleft lip and/or cleft palate should be assessed and evaluated
carefully. The individual’s breathing and signs of airway obstruction, ability to feed, nutritional
intake, weight gain, growth, syndromic associations that require genetic testing, and craniofacial
anomalies need to be evaluated. Additionally, it is important to evaluate the severity and type of
defect, the width of the defect, position of alveolar segments and premaxilla, nasal deformity, the
need for presurgical orthopedics, type of appliance necessary, and prepare the child and parents
for surgical repair of cleft (Bagheri et al. 2011). For this reason, it is vital for individuals with
clefts to be managed by a specialized craniofacial and cleft lip/cleft palate team.
There are several primary goals when managing the alveolar cleft. The goals of a
successful alveolar graft include: creating a continuous maxillary arch, facilitating eruption of
permanent teeth, providing adequate bone support, preserving periodontal health of teeth adjacent
to the cleft, permitting orthodontic tooth alignment, allowing placement of osseointegrated
implants, and improving alar base symmetry. In addition, it is important to contemplate the
effects of surgery and timing of this procedure on continued midface development (Bergland et
al. 1986; Amanat and Langdon, 1991; Cohen et al. 1993; Dempf et al. 2002; Oberoi et al. 2009;
Francis et al. 2013; Linderup et al. 2016; Seifeldin, 2015; Hammoudeh et al. 2017; Fahradyan et
al. 2019).

2.3.3. Treatment Timing
Historically, alveolar bone grafts have been completed at three different time periods
relative to teeth development: at the time of deciduous dentition, at the time of mixed dentition,
and following mixed dentition. Primary bone grafting is performed in the deciduous stage of
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dental development, secondary bone grafting is performed during the mixed dentition, and
tertiary bone grafting is performed following the mixed dentition (Fahradyan et al. 2019).
Primary bone grafting has been shown to have poor results causing orofacial teams to
abandon the technique. To overcome the skeletal, occlusal, and periodontal problems of the
ungrafted cleft, secondary bone grafting has become the technique/surgery of choice. This
technique was popularized by Abyholm et al. (1981), but Boyne and Sands (1972) receive a lot of
the credit for the scientific and biological basis of the technique. Secondary bone grafting of the
alveolar cleft is ideally completed before the eruption of and when two-thirds of the root has
developed on the cleft side canine tooth. This typically ranges from 7-12 years of age, but the
dental age of the patient is a more accurate way to analyze proper treatment timing compared to
chronological age (Amanat and Langdon 1991).
The current standard of deciding on an appropriate treatment time is based on the
radiographic analysis of the cleft side canine root development; however, this method is also
controversial.
2.3.4. Outcomes and Success Rates
Defining a “successful” unilateral alveolar graft may have different meanings for
different specialists. To an oral surgeon, a successful alveolar graft may mean any stability of the
grafting material at the post-graft observation. To an orthodontist, a successful alveolar graft may
mean the improved ability for the canine to erupt normally and enhanced ability to align teeth
within the continuous osseous ridge. Previous studies address success rates for alveolar cleft
grafts as either percent bone fill or percent residual cleft defect following the procedure. These
methods are becoming the new standard to avoid the difficult identification process in
differentiating natural alveolar bone from graft material on CBCT images.
Herford et al. used computed tomography to compare bone morphogenetic proteininduced repair of the premaxillary cleft with the gold standard anterior iliac crest as a graft
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material. This study analyzed 12 total subjects. The average age of patients receiving anterior
iliac crest graft was ten and the average age of patients receiving bone morphogenetic protein
graft was eight. Their post-graft images were captured at 4-months following the surgery and they
concluded an average bone fill of 78.1% and 71.7% for anterior iliac crest and bone
morphogenetic protein respectively (Herford et al. 2007).
Another study analyzed the percentage of bone fill 1-year post-graft using anterior iliac
crest. There were 21 subjects in this study and the average age at the time of alveolar bone
grafting was 10 years 7 months +/- 2 years 8 months. CBCT images were used for measuring the
volumetric values of the alveolar cleft. The authors concluded an 84.1% bone fill for unilateral
alveolar cleft patients with a range of 61.9% to 96.5% (Oberoi et al. 2009).
Francis et al. used occlusal radiographs to compare recombinant human bone
morphogenetic protein-2 with autologous iliac crest bone for repairing alveolar clefts. This study
analyzed 55 consecutive patients with an average age of 11.8 years. Their post-graft images were
captured at an average of 21 months following surgery. The authors defined a successful alveolar
graft as, “those with radiographically evident bony bridging at the cleft site for which no
subsequent regrafting procedure was necessary.” They used the Bergland and Chelsea scale to
evaluate the occlusal radiographs. This study concluded a 94.4% success rate for rhBMP-2 and an
84.2% success rate for anterior iliac crest (Francis et al. 2013).
Dickinson et al. studied older alveolar cleft patients to see if there was reduced morbidity
and improved healing when using bone morphogenetic protein-2 as a graft material. The average
age at surgery was 16.4 +/- 1.5 years and 15.9 +/-1.9 years for the bone morphogenetic protein-2
and anterior iliac crest groups respectively. Panoramic and computed tomography images were
captured pre-graft and 1-year post-graft to determine the results. As far as morbidity, the authors
concluded bone morphogenetic protein-2 to be superior to anterior iliac crest in the following
areas: donor site pain, length of hospital stay, and overall cost of the procedure. As far as bone
healing, this study concluded bone morphogenetic protein-2 to have a larger percentage alveolar
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defect fill (95%) compared to anterior iliac crest (63%) at the 1-year post-graft scan (Dickinson et
al. 2008).
A paper from 2016 analyzed a different grafting material to be used during secondary
alveolar graft procedures. Linderup et al. used mandibular symphyseal bone and CBCT images to
analyze the success rates of alveolar cleft grafting procedures at 1-year post-graft. 32 total
patients were studied with an average age of 9 years 6 months. The authors concluded an 87%
bone fill ratio with a range of 47% to 100% post-graft (Linderup et al. 2016).
Hammoudeh et al. conducted a study using occlusal radiographs to compare alveolar
bone graft success rates using human bone morphogenetic protein-2 and iliac crest bone for graft
materials. The authors defined a successful graft as one that did not require additional surgeries to
repair the defect. Functionally, graft success was evaluated based on the cleft side canine eruption
pattern. If this canine was able to erupt naturally on its own, the graft was deemed a functional
success. This study concluded success rate of alveolar grafts at 88.4% and 90.0% for iliac crest
bone and human bone morphogenetic protein-2 respectively (Hammoudeh et al. 2017).
Finally, in 2011 a systematic review was completed on the results of using bone
morphogenetic protein-2 for alveolar graft procedures. The use of this tissue engineered graft
material has shown favorable results. This study concludes that the use of bone morphogenetic
protein-2 has good results in terms of quantity of bone formation within the cleft, shortens the
operation time, eliminates the donor site morbidity issue, shortens the hospital stay, and reduces
the overall cost (van Hout et al. 2011).
In addition to overall success rates for secondary alveolar grafts, a number of factors are
believed to influence the outcome of alveolar bone grafting. Independent variables have
previously been analyzed to determine their effects on these outcomes. According to previous
studies, there is no significant difference between unilateral and bilateral cleft patients in terms of
success rates. The size of the preoperative alveolar cleft did not appear to influence the success
rates. There was also no significant difference in outcomes when comparing if an adjacent lateral
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incisor was present or not. The developmental stage of the cleft side canine did not statistically
show an effect on the outcomes. And finally, there was no difference in outcomes when
comparing gender differences (Linderup et al. 2016; Oberoi et al. 2009).
2.4. Materials Used for Secondary Alveolar Grafts
Grafting orofacial clefts dates back to the early twentieth century. In 1901, Von
Eiselsberg was the first surgeon to use autogenous bone to graft the maxillary cleft by way of a
free bone sample of the little finger. Lexer was also on the forefront of these methods in 1908. In
1914, Drachter was the first to report the successful closure of a cleft with tibial bone and
periosteum (Lilja 2009). Since these first methods were introduced, various graft materials,
including tibia, calvarium, mandible, rib, and anterior iliac crest have been analyzed and
compared (Linderup et al. 2016). The hope is to find an alveolar cleft graft material that will
allow for the elimination of donor site morbidity, prolonged hospital stays, increased surgical
cost, and post-graft pain while delivering high success rates and allowing for proper physiological
and psychological function of the maxillofacial complex.
Cortical and cancellous bones can be used for grafting orofacial clefts, but cancellous
bone seems better due to the cell transfer and revascularization noticed in osteoinduction and
osteoconduction. Fresh autologous cancellous bone has been reported to be the most ideal bone
graft source because of the increased amount of osteogenic precursor cells within the matrix
(Kang 2017; Seifeldin 2016). Cortical bone takes longer to incorporate at the graft site because it
relies on vascular ingrowth in a process called “creeping substitution.” In addition to being better
in osteoinduction and osteoconduction processes, cancellous bone has also been shown to allow
tooth eruption more often (Coots 2012). Numerous autologous bone donor sites have been used
and studied in hopes to determine an appropriate graft material to meet the goals listed
previously.

18
Bosker and van Dijk were the first to report the use of mandibular symphysis bone as a
grafting material for secondary alveolar grafts in 1980. The mandible has the same embryonic
origin as the maxilla and because it is an intramembranous bone, revascularization is fast and
resorption is minimal (Kang 2017; Seifeldin 2016). This material seemed attractive because it
displayed low morbidity while allowing for satisfactory success rates. Some of the advantages
include: restriction to one intraoral operation site, shorter time in the hospital, minimal
discomfort, and an incision located in the lower labial sulcus leading to an invisible scar.
Disadvantages associated with mandibular symphysis include: limited volume of bone available
for grafting bilateral clefts, a small operation site eliminates the possibility of two operative teams
working at the same time, increased amount of cortical bone in the donor material, and possible
injury to the mental nerve that could result in changes in sensitivity of adjacent teeth/soft tissues
(Coots 2012; Linderup et al. 2016; Rawashdeh and Telfah 2008).
As stated previously, Drachter was the first to use tibial bone to reconstruct alveolar
clefts in 1914. Since then, few authors have reported the tibia as a donor site for alveolar grafts.
The tibia has been extensively used in orthopedic surgeries and is a popular material among
maxillofacial surgeons, however most of the procedures completed with tibia material is seen in
adult patients, and mainly for trauma incidences. Some of the advantages of using tibia as a graft
material include: shorter operation time, minimal scarring, shorter hospital stay, and quicker
ambulation. On the contrary, the disadvantages of using the tibia as a graft material seem to far
outweigh the advantages. These include: lack of available material in younger patients, close
proximity to the growing epiphyseal cartilage, possibly needing to take material from both legs,
proximal tibial fractures (reported in the range of 0-2.7%), and the need to avoid contact sports
for at least three months (Kang 2017; Rawashdeh and Telfah 2008; Seifeldin 2016).
Another graft material that has been studied is calvarial bone. This material has shown
similar success rates for alveolar grafts when compared to iliac crest bone. Some of the
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advantages for using calvarial bone include: inconspicuous scar formation, lack of functional
deformity, appropriate surgical field, and volume of bone that can be harvested. However, there
are high risk disadvantages that go along with this material and complication rates range from
0.25-5.5%. These include: long operative time, wound infection, minimal cancellous bone, thin
bone, and intracranial complications such as hematoma, dural tear, dural exposure, and
cerebrospinal fluid leakage. Calvarial bone is most often suggested for patients who do not have a
high chance of multiple head injuries such as athletes (Kang 2017; Rawashdeh and Telfah 2008;
Seifeldin 2016).
Autogenous bone taken from the anterior iliac crest is considered the most common
method and optimal material for grafting alveolar clefts and is thus termed the “gold standard
bone graft.” It has also been shown that this material should be the standardized graft to which
other types of alveolar bone grafts should be compared. Some advantages of using anterior iliac
crest include: provides a large quantity of cancellous bone, has easy surgical access, great
osteogenic potential with abundant pluripotent osteogenic precursor cells. The disadvantages
associated with using iliac crest for grafting alveolar clefts include: hematoma, pain, delayed
ambulation, prolonged hospital stay, possible scaring, and risk of cutaneous nerve injury (Kang
2017; Rawashdeh and Telfah 2008; Seifeldin 2016). To help reduce these complications, limited
incision, reduced musculature elevation, hemostasis, adequate pain control, and quick ambulation
are suggested (Kang 2017).
To eliminate the donor site morbidity and other complication with autogenous bone
grafts, tissue engineering has become a popular concept for developing an alternative to the
previously studied graft materials used for secondary alveolar grafting procedures. Three vital
components are necessary for tissue engineering and include: bone-forming cells, osteoinductive
growth hormone, and an osteoconductive scaffold. The scaffold provides mechanical support,
mimics the bony matrix, and guides the formation of bone in the defect area. This scaffold can
serve as a carrier for the osteoinductive growth hormone. This hormone is thus delivered locally

20
and ideally over a sustained period of time to recruit mesenchymal stem cells to differentiate into
osteogenic cells (van Hout et al. 2011).
With these novel methods of producing and delivering graft material alternatives, many
of these materials have been studied and their success rates have been analyzed. One of the most
commonly used substitutes for secondary alveolar grafts is recombinant human bone
morphogenetic protein-2 (rhBMP-2). rhBMP-2 was initially identified by Marshall Urist, an
orthopedic surgeon conducting research on bone mineralization, and Strates in the 1960’s. These
proteins are involved in the natural formation and development of the human skeleton. Very
small quantities are contained in the mature skeleton and are associated with bone maintenance
and fracture repair. Early on, Urist placed demineralized, lyophilized segments of allogeneic bone
matrix into muscle pockets in rabbits and watched as bone was formed. This led him to postulate
the concept that these proteins, located within the matrix, can promote the formation of
osteoblasts (Chin et al. 2005).
rhBMP-2 belongs to the transforming growth factor-superfamily of proteins. This
protein induces bone and cartilage formation through signal pathways (Hammoudeh et al. 2017).
They are essential for skeletogenesis in the embryo and for bone remodeling throughout life.
Supraphysiologic levels of these proteins promote de novo bone generation (Francis et al. 2013).
Bone morphogenetic proteins (BMPs) in general were approved by the United States
Food and Drug Administration (FDA) for maxillary sinus augmentation in 2004 and alveolar
ridge augmentation following dental extraction in 2007. Although rhBMP-2 has been shown to
have favorable outcomes as an alternative grafting material, it has been considered to be off-label
for the use of grafting alveolar clefts (Francis et al. 2013; van Hout et al. 2011). Despite the
approval for augmentation procedures, rhBMP-2 has raised concerns over its use for grafting
orofacial clefts. An initial U.S Food and Drug Administration warning was issued after accounts
of post-graft dysphagia and airway compromise due to swelling in patients who received it
around the cervical spine. Another U.S FDA warning was issued in 2015 for safety issues arising
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with the use of rhBMP-2 in the pediatric population out of concern for insufficient data to
represent long-term safety and efficacy (Hammoudeh et al. 2017). However, in recent years
several groups and research teams have reported experiences using rhBMP-2 off-label for
alveolar cleft reconstruction in the pediatric population (Francis et al. 2013).
A study conducted at the Children’s Hospital Los Angeles prior to the U.S. FDA warning
on rhBMP-2 compared the outcomes of using rhBMP-2 vs iliac crest as a grafting material for
alveolar clefts in the pediatric population. A demineralized bone matrix was used as the carrying
scaffold during the procedures. During a 10-year period, this study did not observe an increase in
evidence of infection, heterotopic ossification, malignant transformation, or airway compromise
for the patients receiving rhBMP-2 (Hammoudeh et al. 2017). This study was a pivotal point in
the introduction of rhBMP-2 as an attractive alternative to the previous gold standard, iliac crest,
for secondary grafting of alveolar clefts in younger patients. rhBMP-2 has also been shown to
display improved bone healing and decreased post-graft pain in adult patients receiving alveolar
cleft grafts when compared to iliac crest (Dickinson et al. 2008).
Overall, rhBMP-2 appears to be an attractive alternative graft material to the previous
gold standard, iliac crest. It would allow for the elimination of donor site morbidity, decrease the
post-graft pain, reduce the overall cost of the procedure, limit hospital stay, and promote postgraft ambulation while still allowing for high success rates for alveolar graft procedures.

2.5. Cone Beam Computed Tomography to Evaluate Alveolar Graft Procedures
Up until recently, the majority of secondary alveolar graft studies have been conducted
using two-dimensional radiographs, such as occlusal, panoramic, and periapical films. These
studies have used these images, along with either the Bergland scale (Figure 2.5.1) or Chelsea
scale (Figure 2.5.2), to evaluate the alveolar cleft defect area and to understand the outcomes of
secondary alveolar grafts (Trindade et al. 2005). In the Bergland scale system, a four-point
system was used to classify each graft depending on the coronal level of the interdental bone
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compared to normal levels. One of the main shortcomings with this system was that the graft was
compared only at the interdental level using normal bone levels for reference values (Seifeldin
2016).
There are obvious shortcomings in attempting to determine the outcomes of alveolar bone
grafts from 2-dimensional images. They do not accurately quantify the 3-dimensional pyramidal
shape of the alveolar cleft of interest and could initiate errors when determining the true defect
volume. Computed tomography (CT) was one of the first radiographic techniques used to 3dimensionally view the alveolar cleft entirely. Because traditional CT images had high radiation
doses, long scan times, and low quality/low resolution images, other radiographic methods were
discovered. Between 1998 and 1999, cone-beam (CB) systems were introduced for oral and
maxillofacial images and replaced the traditional CT images allowing for limited radiation doses
(approximately 15-times less), minimal scanning time (10-70 seconds), and high
quality/resolution images (Seifeldin 2016). Over the last decade, the orthodontic and dental field,
as a whole, has adopted the use of CBCT for diagnosis, treatment planning, and reduction of
radiation dose compared to conventional tomography (Ludlow et al. 2015).
Various 3-dimensional software have been reported and used in the identification,
segmentation, and quantification of orofacial and alveolar clefts. Software such as Amira 3.1.1,
Mimics 15.0; Materialise Interactive Medical Image Control System, and ITK-SNAP 3.8.0 have
been reported throughout the orthodontic literature in regards to determining/measuring
volumetric values of alveolar clefts.
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CHAPTER 3: RESEARCH HYPOTHESIS & SPECIFIC AIMS
3.1. Statement of the Problem
Bone grafting of alveolar clefts is an essential component in the contemporary
management of patients with orofacial clefts. The search for an appropriate alternative to the
autogenous graft material, such as anterior iliac crest, has included experiments with many
substitutes. However, alveolar bone graft outcomes of rhBMP-2, as an alternative to autogenous
sources, in unilateral alveolar cleft patients is yet to be studied. Determining the appropriate
timing for this procedure to produce the best outcome is also still controversial. Chronological
age, root development of the cleft side canine, and stage of dental maturity have all been used to
estimate the most appropriate time to graft the alveolar cleft. Additionally, there may be other
factors that need to be analyzed to determine the proper timing of alveolar bone graft procedures
and to better estimate the success rates of these grafts.
Intraoral occlusal and periapical radiographs have been used to evaluate bone fill within
an alveolar cleft and to map segmentally the height, thickness, and position of bone adjacent to
the roots of the cleft. With the shortcomings associated with analyzing a three dimensional
structure using two dimensional radiographs, the use of three-dimensional CBCT radiography has
become a popular alternative. CBCT imaging would allow one to better appreciate the severity,
location, and overall graft outcome of unilateral alveolar clefts. Since this technology is readily
available and reliable, it could be utilized to investigate the clefts pre-graft as well as post-graft to
determine the overall success rates. This knowledge is essential to be able to foresee what
variables affect the graft outcomes. This information can be used to aid practitioners in
understanding the severity of the orofacial cleft, treatment planning the alveolar graft procedure,
and assist in preventing negative sequelae.
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3.2. Central Research Hypothesis
The central research hypothesis is that there will be a difference in secondary alveolar
graft success rates when comparing: gender, age, side of the cleft, canine root development,
canine angulation in both the coronal and sagittal planes, and canine distance from the occlusal
plane and their effects on these outcomes using 3-dimensional software for analysis.

3.3. Specific Aims
1) To determine the overall success rate of using rhBMP-2 for unilateral secondary
alveolar cleft grafts using CBCT radiography.
2) To determine if gender, age, side of the cleft, canine root development, canine
angulation in both the coronal and sagittal planes, or canine distance from the occlusal plane have
an influence on these success rates using CBCT radiography.
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CHAPTER 4: MATERIALS & METHODS
4.1. Study Design
This study is a retrospective comparison of pretreatment and post-treatment CBCT
images of patients with unilateral alveolar clefts who received secondary alveolar bone grafts at
the University of Nebraska Medical Center Oral and Maxillofacial Surgery Center in Omaha,
Nebraska. This study protocol was reviewed and approved by the University of Nebraska Medical
Center Institutional Review Board (#113-20-EP) and the Boys Town National Research Hospital
Institutional Review Board (#20-03-X).

4.1.1. Data Collection
It is routine for patients with cleft lip and palate to see a craniofacial and cleft lip/cleft
palate team for proper management. The team at Boys Town National Research Hospital consists
of a wide range of specialists including: pediatrician, orthodontist, oral surgeon, plastic surgeon,
otolaryngologist, speech pathologist, audiologist, craniofacial nurse, genetic counselor, social
worker, and a nutritionist. Dr. V.D. is the oral surgeon on this Boys Town National Research
Hospital team. He routinely collects a pre-graft CBCT radiograph for the orofacial cleft patients
requiring alveolar cleft grafting procedures. The information from this image is used to diagnose
problems, create treatment objectives, and formulate a comprehensive treatment plan.
Additionally, Dr. V.D. routinely captures a 6-month post-graft CBCT radiograph to monitor the
success rates and analyze the graft material uptake/residual defect.
Consecutive patients with unilateral alveolar clefts who received secondary alveolar bone
grafts from Dr. V.D., from June 1, 2014 to January 1, 2020, were selected for this study.
Inclusion criteria for this study included: patient age between 7-13 years old at the time of the
alveolar graft surgery, patients with unilateral alveolar cleft, patients who used rhBMP-2 as the
graft material, and access to available pre-graft and post-graft CBCT images. Exclusion criteria
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included patients who received an alveolar bone graft previously, patients who have had a failed
bone graft, those with bilateral alveolar clefts, and patients who received anterior iliac crest bone
graft. 24 patients were included in this study and their pre-graft and post-graft CBCT images were
analyzed.
CBCT images were acquired using a Kodak 9500 3D scanner (Kodak Dental Systems,
Carestream Health, Rochester, NY). The orofacial cleft was captured with the following settings:
tube potential of 90kV, current of 10mA, 3.6 second exposure time, 0.2mm scanning layer
thickness, and 200um voxel size. All data sets with DICOM (Digital Imaging and
Communications in Medicine) format were transferred to Invivo5 (version 5.2; Anatomage
Dental, San Jose, California) for storage and interpretation.
The DICOM data were exported and scanned to university protected disks at the
University of Nebraska Medical Center Oral and Maxillofacial Surgery Center. All data was
uploaded to the University of Nebraska Medical Center protected database to ensure patient
confidentiality. DICOM data were imported to Precision Workstation T3600 desktop computer
(Dell, Round Rock, TX) with appropriate imaging software as described in subsequent sections.
All images were viewed on a 60.47 cm LED widescreen display monitor screen (Dell) having a
resolution of 1920 x 1080 pixels.
Demographic and treatment variables were recorded for each patient based on the
information obtained from the patients’ charts. Age of the patient at the time of surgery, graft
material used during the procedure, side of the unilateral cleft, and gender of the patient were
documented for analysis.

4.1.2. Surgical Technique
All grafting procedures were performed under general anesthesia with orotracheal
intubation. Patients received preoperative prophylactic antibiotic therapy of cefazolin or
clindamycin, if allergic to cefazolin. A one surgeon team completed the unilateral grafts using
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rhBMP-2 (INFUSE, Medtronic; Memphis, Tennessee). The same surgeon, Dr. V.D., performed
all the procedures to help standardize the case results. Deciduous and supernumerary teeth in the
direct vicinity of the unilateral alveolar cleft were extracted one to three months prior to the
surgery. This was completed to aid in grafting outcomes and facilitate mucosal flap design
utilizing increased keratinized epithelium.
The surgical procedure for grafting of unilateral alveolar clefts was followed as described
by Boyne and Sands (Boyne and Sands 1972) with and without the modification of strut
technique described by Stoelinga et al. (Stoelinga et al. 1990). Several other modifications were
used during these surgical procedures including: the use of 4-0 Vicryl to close the nasal mucosa,
the use of 3-0 and 4-0 Vicryl to close the oral mucosal flaps, and the application of cyanoacrylate
to the reconstructed nasal floor and oral mucosal tissues after closure.
For grafting these unilateral alveolar cleft patients, 0.7cc to 1.4cc (1.05mg to 2.10mg)
rhBMP-2 with acellular collagen sponge carrier was used. An allogeneic demineralized human
cortical bone strut (OsteoWrap, Bacterin; Belgrade, Montana) was also used during the
procedure.
Postoperatively, all patients were treated with five days of cephalexin or clindamycin,
advised to have a soft diet for one month, and no strenuous activity recommended for two weeks.

4.2. Linear Measurements
Root lengths of the maxillary canines were measured in millimeters to the nearest
hundredth decimal value with specific attention given to the canine on the side of the alveolar
cleft. These lengths were measured on CBCT images within the open source segmentation ITKSNAP 3.8.0 software. Measurements were taken at the following time points: pre-graft and 6month post-graft. Two separate linear measurements were taken from the cementoenamel
junction (CEJ) to the apex of the tooth in the CBCT layer/slice representing the direct long axis of
the canine tooth (Figure 4.2.1). The method for measuring root length was based on methods in
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previous studies. The canine root lengths were compared to average mature maxillary canine root
length values reported to determine the percentage of canine root development at the time of
alveolar grafting. The average mature maxillary canine root lengths used as references were 15.83
+/- 1.49mm and 15.23 +/- 1.78mm for males and females respectively (Kim et al. 2013).
CBCT images were analyzed using ITK-SNAP 3.8.0 in both the coronal and sagittal
sections to determine the angulation of the cleft side maxillary canine tooth in relation to a true
perpendicular reference line. These values were measured in degrees and recorded to the nearest
tenth decimal value. In the coronal section, a reference line was traced on the true vertical
crosshair. Then, a second line was traced through the long axis of the cleft side canine passing
through the apex of the tooth (Figure 4.2.2). These angular measurements were recorded for both
the pre-graft and post-graft time periods with attention given to the pre-graft values.
Additionally, the angulation of the cleft side maxillary canine tooth was measured in the
sagittal section. In this view, a reference line was traced on the true horizontal crosshair. A
second line was traced through the long axis of the cleft side canine passing through the apex of
the tooth (Figure 4.2.3). These values were recorded for both the pre-graft and post-graft time
periods with attention given to the pre-graft values.
The final linear measurement measured was the distance of the cleft side canine tooth to
the defined occlusal plane. This was measured in millimeters to the nearest hundredth decimal.
Using the ITK-SNAP 3.8.0 software, the CBCT images were viewed in the sagittal section. A
reference line was created from the most inferior aspect of the mesial cusps on the permanent first
molar to the most inferior portion of the central incisor on the alveolar cleft side (through all
layers/slices). This reference line was defined as the occlusal plane in this study for all patients.
Next, a line was inserted from the most inferior tip of the cleft side canine tooth to the defined
occlusal plane reference line. These two lines always formed a 90-degree angle at their
intersection. These values were recorded for both the pre-graft and post-graft time periods with
attention given to the pre-graft values.
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Two investigators (L.P. and S.P.) each independently completed the root length
measurements on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these same 10
patients (20 CBCT scans) were analyzed by the same two investigators independently. These
measurements were used to determine the intra-examiner and inter-examiner reliability of the
method used. Once the reliability of the method was established, each investigator completed the
root length measurements for one-half of the total sample number.
The cleft side canine angulation measurements and distance from the occlusal plane
measurement were performed by investigator L.P. Again, these three measurements were initially
completed on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these same 10 patients
(20 CBCT scans) were analyzed by the same investigator. These measurements were used to
determine the intra-examiner reliability of the method.

4.3. Volumetric Measurements
The unilateral maxillary alveolar cleft volumes were determined from the pre-graft and 6month post-graft CBCT images using the open source segmentation software ITK-SNAP 3.8.0.
These volumes were measured in cubic millimeters to the nearest hundredth decimal.
The first step in segmentation was using the semi-automatic, or “active contour
segmentation mode (5)”, feature in ITK-SNAP 3.8.0. A large region of interest was set in the
axial, coronal, and sagittal planes to encompass the desired alveolar cleft defect as well as a large
portion of the maxillary arch and adjacent teeth (Figure 4.3.1). The “Active Label” was changed
to a green color, representing bone and/or hard tissue. The pre-segmentation mode was used to
adjust the contrast and instruct the software algorithm to separate bone/teeth voxels from soft
tissue voxels. Within the inverted image, the upper threshold limit was increased to the maximum
to limit variability between pretreatment and post-treatment images. The lower threshold limit
was chosen by the investigator, for each CBCT image, based on adequate bone to soft tissue
differentiation. The smoothness parameter was also set to the maximum value to help standardize
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the results and limit inaccurate segmentation (Figure 4.3.2). The initialization mode allowed the
investigator to place pre-set bubbles to communicate areas of interest to the software (Figure
4.3.3). Other parameters used during the auto-segmentation feature were setting the step size to 2
and allowing the iteration to run until 600 and 1000 for pre-graft and post-graft CBCT images
respectively. Automatic segmentation was allowed to proceed until the raw segmentation began
to involve adjacent structures (Figure 4.3.4).
Once the bone and/or hard tissues were segmented out, the polygon mode (3) was used
for manual segmentation of the alveolar cleft defect. The feature allows for segmentation in the
three orthogonal slices. The “Active Label” was changed to a red color, representing soft tissue,
and the segmentation could be painted in any “clear labels” within the ITK-SNAP software
(Figure 4.3.5). The polygon mode tool was used to trace out the defect through all slices included
in the region of interest that was set based on previous papers. The protocol for setting up the
region of interest was adopted from and very similar to that of Linderup (Linderup et al. 2015).
The boundaries for the region of interest can be seen in Table 4.3.1. The superior boundary was
determined to be ten slices inferior to the anterior nasal spine (ANS); confirmed on the coronal
section as a radiopaque dot. The inferior boundary was determined to be the most apical portion
of the palatal CEJ of the adjacent tooth. The anterior and posterior boundaries were determined
by the anatomical structure of the contralateral alveolar ridge within the slice being analyzed. The
medial and lateral boundaries were determined by the initial auto-segmentation process of
labeling the bone and/or hard tissues.
Two investigators performed the volumetric measurements of the unilateral alveolar cleft
defects. Both investigators were calibrated to eliminate any bias or structural identification errors
during manual segmentation. These calibrations were used to minimize the human error presented
in the potential artistic interpretation. After the final segmentation was achieved for the region of
interest (Figure 4.3.6), the volumetric value was recorded from the “volumes and statistics” tab in
ITK-SNAP 3.8.0. (Figure 4.3.7).
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Two investigators (L.P. and S.P.) each independently completed the unilateral alveolar
cleft volume measurements on 10 patients (20 CBCT scans). After a minimum of 2 weeks, these
same 10 patients (20 CBCT scans) were analyzed by the same two researchers independently.
These measurements were used to determine the intra-examiner and inter-examiner reliability of
the method used. Once the reliability of the method was established, each researcher completed
the volumetric measurements for one-half of the total sample number.

4.4. Statistical Analysis
All data were entered into Excel (version 2016; Microsoft, Redmond, Wash). The PROC
GLIMMIX procedure in SAS 9.4 (SAS Institute; Cary, NC) was used to analyze the percent
residual defect in relation to the explanatory variables of interest. Residual and quantile-quantile
plots (QQ-plots) were used to asses model fit. A generalized linear model following a beta
distribution with a logit link was used to account for the underlying distribution of the percent
residual defect. When differences occurred, least significant difference (LSD) was reported at the
 = 0.05 level. A total sample size of 24 subjects was analyzed for the volumetric and linear
measurements.
To assess the reliability of the methods used in this study, duplicate measurements were
taken on ten consecutive patients at least two weeks apart. Intra-class correlation coefficients
(ICCs) were calculated for intra-examiner and inter-examiner reliability using R version 3.6.3 (R
Core Team; Vienna, Austria). ICC3 values were used when all subjects are rated by the same
raters who are assumed to be the entire population of raters. These values are reported because we
are interested in how investigators (LP and SP) are rating the measurements and do not care to
extend it to other potential raters.
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4.5. Intra-examiner and Inter-examiner Reliability
Intra-examiner reliability was measured with intra-class correlation coefficients (ICCs)
using R version 3.6.3 (R Core Team; Vienna, Austria). It was determined by repeating the
volumetric and cleft side canine root length linear measurements on ten patients by the original
investigator (LP or SP) at least two weeks after the initial measurements on pre-graft and postgraft CBCT images. Intra-examiner reliability was also measured for the cleft side canine
angulation and distance from the occlusal plane linear measurements. These were measured by
investigator (LP) on ten patients. At least two weeks later, these measurements were repeated on
the same ten patients by the same investigator (LP) for the pre-graft and post-graft CBCT images.
Inter-examiner reliability was determined by comparing the volumetric and cleft side
canine root length linear measurements on ten patients for pre-graft and post-graft CBCT images
using R version 3.6.3 (R Core Team; Vienna, Austria). The inter-examiner reliability was
determined on the same ten patients selected for the intra-examiner reliability test. Again, the
inter-examiner reliability was measured with intra-class correlation coefficients (ICC3).
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Figure 2.1.1: Normal Embryologic Facial Development. Five prominences are shown during
the second (left), fifth (middle), and eighth (right) week of embryologic development. These
prominences normally fuse with each other as well as other prominences to develop anatomical
structures. Disturbances in normal fusion of any of these prominences can lead to congenital
defects. Graphics by K. Theesen. Additional credit to Sperber et al. 2001.
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Figure 2.1.4: Kernahan Striped “Y” Classification System. To date, this is one of the most
commonly used systems for classifying orofacial clefts. Depending on the anatomical location
or extent of the cleft, a numerical value is given to the orofacial cleft. The incisive foramen (red
text above) is used as a boundary point between the primary palate (#3 & #6) and hard palate
(#7 & #8). Additional credit to Rani and Chickmagalur 2011.
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Figure 2.2.1: Alveolar Cleft Shape. Classic pyramidal shape of an alveolar cleft. The medial
and lateral boundaries are determined by the extent of the cleft (red and purple text above).
The superior boundary is determined by the nasal floor (blue text) and the inferior boundary is
determined by the palate/posterior alveolus (orange text). The anterior boundary is determined
by the anterior portion of the alveolus (green text). Additional credit to Craven et al. 2007.
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Figure 2.5.1: Bergland Scale. This scale evaluates the amount of bone produced in the cleft
site based on the height of the intraalveolar septum on 2-dimensional images. Heights are
measured in between the adjacent teeth with a superior and inferior border. The superior
border is defined by a line between the tips of the roots of the adjacent teeth. The inferior
border is defined by the cementoenamel junction coronally. 1: normal height 2: less than
normal height by greater than 75 percent of normal bone height 3: less than 75 percent of
normal bone height 4: no bone bridge in the cleft site. Additional credit to Trindade et al.
2005.
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Figure 2.5.2: Chelsea Scale. This scale evaluates and quantifies the amount of ossification
within the alveolar cleft site. Bone fill of 100 percent in the alveolar cleft defect is represented
by a score of 8 (left). Partial scores of 0.5 can be used and are counted for sectors that have
partial bone fill but lack bony bridging across the alveolar cleft site (right). Additional credit
to Trindade et al. 2005.
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Figure 4.2.1: Cleft Side Canine Root Length Measurement. Sagittal view of an immature
canine on the side of the unilateral alveolar cleft. Two separate linear measurements were taken
from the cementoenamel junction (CEJ) to the level of the apex in the CBCT layer/slice most
accurately representing the direct long axis of the canine tooth. This was usually determined in
the coronal or sagittal (shown above) views within the ITK-SNAP 3.8.0 software. The two
values were averaged and the mean value was recorded for comparison to previously reported
adult canine root length measurements.
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Figure 4.2.2: Cleft Side Canine Angulation; Coronal Section. Coronal view of the cleft side
canine within ITK-SNAP 3.8.0. The first line (red) was made on the true vertical crosshair
approximately located at the midline. The second line (also red) was traced down the long axis
of the cleft side canine tooth. The software automatically calculated the angle formed between
these two lines and this value was recorded.
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Figure 4.2.3: Cleft Side Canine Angulation; Sagittal Section. Sagittal view of the cleft side
canine within ITK-SNAP 3.8.0. The first line (red) was made on the true horizontal crosshair.
The second line (also red) was traced down the long axis of the cleft side canine tooth. The
software automatically calculated the angle formed between these two lines and this value was
recorded.
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Figure 4.3.1: Region of Interest for Semi-automatic Mode. Axial view of the region of
interest for the semi-automatic mode within ITK-SNAP 3.8.0. It has been set in the axial,
sagittal, and coronal planes. This region (red dotted lines above) includes the unilateral
alveolar cleft as well as a large portion of the adjacent maxillary alveolar ridges and teeth.
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Figure 4.3.2: Active Contour Evolution Parameters in ITK-SNAP 3.8.0. Within ITK-SNAP
3.8.0, the upper limit and smoothness parameters were set to the maximum values. The lower
limit was chosen by the investigator, for each CBCT image, based on adequate bone to soft tissue
differentiation (250 in the image above). These parameters were set in each CBCT scan to help
reduce the inaccuracy of the auto-segmentation mode.
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Figure 4.3.3: Pre-set Bubbles in the Initialization Mode. The contrasted views above show
hard tissue (white) and soft tissue (blue) within the initialization mode of ITK-SNAP 3.8.0.
Green was selected as the “active label” for bone and/or hard tissues. Bubbles were manually
placed on the hard tissue areas to assist the software in differentiating between the tissues.
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Figure 4.3.4: Auto-segmentation of Bone and/or Hard Tissues. Axial, sagittal, and coronal
views of the segmented-out bone and/or hard tissues (green). This is the stage after autosegmentation has been completed in ITK-SNAP 3.8.0. Note the medial and lateral boundaries
for the alveolar cleft have been determined at this stage.
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Figure 4.3.5: Polygon Mode; Manual Segmentation of the Cleft. Within ITK-SNAP 3.8.0.,
the unilateral alveolar cleft was manually segmented on the axial view. The superior most
boundary was determined by ten slices inferior to ANS and the inferior most boundary was
determined by the palatal portion of the CEJ on the adjacent incisor tooth. Through these slices,
the anterior and posterior boundaries of the cleft were determined from the anatomical
structures of the contralateral side. The software filled in the defect in all three planes shown
above (red color).
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Table 4.3.1: Region of Interest Boundaries for Manual Segmentation. Definitions of the
region of interest boundaries used during the manual segmentation process within ITK-SNAP
3.8.0. These definitions were adopted from and very similar to a previous paper by Linderup et
al. 2015.
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Figure 4.3.6: Final Volumetric Segmentation Image in ITK-SNAP 3.8.0. Example of a left
side unilateral alveolar cleft segmented in ITK-SNAP 3.8.0. software for final analysis. Green:
bone and/or hard tissues Red: soft tissues representing the alveolar cleft defect. Note the
“tornado” shape of this pyramidal cleft defect.
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Figure 4.3.7: Final Volumetric Measurement in ITK-SNAP 3.8.0. “Volumes and Statistics”
tab within ITK-SNAP 3.8.0. Green: bone and/or hard tissue volume segmented Red: soft tissue
representing the cleft defect segmented. These values were recorded in an excel file for final
analysis.
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CHAPTER 5: RESULTS
5.1. Subjects
The records of all the patients who have received secondary alveolar bone grafts at the
University of Nebraska Medical Center Oral and Maxillofacial Surgery Center from June 1, 2014
to January 1, 2020 were retrieved. Twenty four patients were included in this study after
application of the exclusion and inclusion criteria and their pre-graft and 6-month post-graft
CBCT scans were analyzed. Of the 24 patients, one was excluded as the graft surgery was
deemed a failure. Data collected from 23 patients were submitted for statistical analysis. The
average age of the patients in this study was 10 years 3 months (range = 8-13 years; SD = 1 year
6 months). Of the 23 patients included, 12 were female and 11 were male. There were 13 leftsided unilateral alveolar clefts and 10 right-sided unilateral alveolar clefts.

5.2. Demographic Variables and Their Effects on Outcomes
5.2.1. Gender
The effect of gender on the alveolar bone graft outcomes was evaluated. Figure 5.2.1.1
displays the raw percent residual defect reported for male and female patients. When analyzing
percent residual defect using a generalized linear model (GLM) following a beta distribution with
a logit link function, Table 5.2.1.1 shows that there is a statistically significant difference in the
true mean percent residual defect between males and females (F=10.63; DF=1,21; p=0.0037).
The least square means for the mean percent residual defect by male and female can be
viewed in Table 5.2.1.2. The estimated mean percent residual defect for females is 20.52%
(Standard Error = 4.2%) and we are 95% confident the true mean percent residual defect for
females is between 13.1% and 30.68%. The estimated mean percent residual defect for males is
44.20% (Standard Error = 5.7%) and we are 95% confident the true mean percent residual defect
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for males is between 32.93% and 56.1%. This information can also be reported and visualized in
a plot with error bars indicting the 95% confidence interval (Figure 5.2.1.2).

5.2.2. Age of the Patient at the Time of Grafting
Age of the patient at the time of grafting was evaluated to determine if it had an effect on
alveolar bone graft outcomes. Figure 5.2.2.1 displays the raw percent residual defect reported for
age of patient at the time of grafting. When analyzing percent residual defect using a GLM
following a beta distribution with a logit link function, Table 5.2.2.1 shows that there is no
statistically significant relationship between the percent residual defect and the age of the patient
at the time of grafting (F=0.00; DF=1,21; p=0.97).
The regression coefficient estimates for the intercept, age of the patient at the time of
grafting, and residual variance (scale) can be viewed in Table 5.2.2.2. Note that these estimates
are on the model scale (non-normal data distribution) and will not have a direct interpretation
other than direction of the slope. For percent residual defect and age of the patient at the time of
grafting, the estimated slope is negative with a value of -0.00466 (standard error = 0.1297).
5.2.3. Side of the Alveolar Cleft
The effect of side of the alveolar cleft on the alveolar bone graft outcomes was evaluated.
Figure 5.2.3.1 displays the raw percent residual defect reported for left and right side alveolar
clefts. When analyzing percent residual defect using a GLM following a beta distribution with a
logit link function, Table 5.2.3.1 shows that there is no statistically significant difference in the
true mean percent residual defect between left and right side alveolar clefts (F=0.6; DF=1,21;
p=0.45).
The least square means for the mean percent residual defect by left and right side alveolar
clefts can be viewed in Table 5.2.3.2. The estimated mean percent residual defect for the left side
alveolar cleft is 34.46% (Standard Error = 5.7%) and we are 95% confident the true mean percent
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residual defect for left side alveolar cleft is between 23.67% and 47.12%. The estimated mean
percent residual defect for the right side alveolar cleft is 28.06% (Standard Error = 6.0%) and we
are 95% confident the true mean percent residual defect for right side alveolar cleft is between
17.31% and 42.08%. This information can also be reported and visualized in a plot with error
bars indicting the 95% confidence interval (Figure 5.2.3.2).

5.3. Linear Values and Their Effects on Outcomes
5.3.1. Cleft Side Canine Root Length
Root length of the canine on the alveolar cleft side was measured to determine if it had an
effect on the outcome of the alveolar bone grafts. The lengths were compared to previously
reported mature maxillary canine root length values and analyzed as a percent. Figure 5.3.1.1
displays the raw percent residual defect reported for the cleft side canine root length percent.
When analyzing percent residual defect using a GLM following a beta distribution with a logit
link function, Table 5.3.1.1 shows that there is no statistically significant relationship between the
percent residual defect and cleft side canine root length percent (F=0.61; DF=1,21; p=0.44).
The regression coefficient estimates for the intercept, cleft side canine root length
percent, and residual variance (scale) can be viewed in Table 5.3.1.2. Note that these estimates
are on the model scale (non-normal data distribution) and will not have a direct interpretation
other than direction of the slope. For residual defect and percent root length of the canine on the
cleft side, the estimated slope is negative with a value of -0.9491 (standard error = 1.22).
5.3.2. Cleft Side Canine Angulation; Coronal Section
Angulation, in the coronal section, of the canine on the alveolar cleft side was measured
to determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure
5.3.2.1 displays the raw percent residual defect reported for the cleft side canine angulation in the
coronal section. Even though there is a slight upward trend, this was not statistically significant.
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When analyzing percent residual defect using a GLM following a beta distribution with logit link
function, Table 5.3.2.1 shows that there is no statistically significant relationship between the
percent residual defect and cleft side canine angulation in the coronal section (F=2.15; DF=1,21;
p=0.15).
The regression coefficient estimates for the intercept, angulation of the canine on the cleft
side in the coronal section, and residual variance (scale) can be viewed in Table 5.3.2.2. Note that
these estimates are on the model scale (non-normal data distribution) and will not have a direct
interpretation other than direction of the slope. For residual defect and angulation of the canine on
the alveolar cleft side in the coronal section, the estimated slope is positive with a value of
0.03561 (standard error = 0.024).

5.3.3. Cleft side Canine Angulation; Sagittal Section
Angulation, in the sagittal section, of the canine on the alveolar cleft side was measured
to determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure
5.3.3.1 displays the raw percent residual defect reported for the cleft side canine angulation in the
sagittal section. Even though there is a slight downward trend, this was not statistically
significant. When analyzing percent residual defect using GLM following a beta distribution with
logit link function, Table 5.3.3.1 shows that there is no statistically significant relationship
between the percent residual defect and angulation of the canine on the cleft side in the sagittal
section (F=0.13; DF=1,21; p=0.72).
The regression coefficient estimates for the intercept, angulation of the canine on the cleft
side in the sagittal section, and residual variance (scale) can be viewed in Table 5.3.3.2. Note that
these estimates are on the model scale (non-normal data distribution) and will not have a direct
interpretation other than direction of the slope. For residual defect and angulation of the canine on
the alveolar cleft side in the sagittal section, the estimated slope is negative with a value of 0.00592 (standard error = 0.016).
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5.3.4. Cleft Side Canine Distance from the Occlusal Plane
Distance of the canine on the alveolar cleft side from the occlusal plane was measured to
determine if it had an effect on the outcome of the secondary alveolar bone graft. Figure 5.3.4.1
displays the raw percent residual defect reported for the cleft side canine distance from the
occlusal plane. When analyzing percent residual defect using GLM following a beta distribution
with logit link function, Table 5.3.4.1 shows that there is no statistically significant relationship
between the percent residual defect and distance of the canine on the cleft side from the occlusal
plane (F=0.11; DF=1,21; p=0.74).
The regression coefficient estimates for the intercept, cleft side canine distance from the
occlusal plane, and residual variance (scale) can be viewed in Table 5.3.4.2. Note that these
estimates are on the model scale (non-normal data distribution) and will not have a direct
interpretation other than direction of the slope. For residual defect and distance of the canine on
the alveolar cleft side from the occlusal plane, the estimated slope is positive with a value of
0.01404 (standard error = 0.042).
5.4. Volumetric Values and Percent Residual Defect
Volume of the clefts were measured to determine the overall success rate of using
rhBMP-2 as a grafting material during secondary alveolar bone grafts. Pre-graft and 6-month
post-graft CBCT images were analyzed for the 23 patients. Table 5.4.1 displays the observed cleft
volumes (in mm3) for the subjects included in this study. Overall, the mean pre-graft volume of
the unilateral cleft was 1026.97 (SD = 390.11) and the mean post-graft volume of the unilateral
cleft was 333.48 (SD = 250.94). Table 5.4.1 also outlines the mean volume values for
male/female and left/right side alveolar cleft. This information is also represented in a box &
whisker plot with the inner quartile range displayed (Figure 5.4.1).
To report the success rates of secondary alveolar bone grafts, we reported our
measurements as a percent residual defect calculated from the pre-graft and post-graft CBCT
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scans. Overall, the mean percent residual defect was 0.32 (32%) (SD = 0.22) meaning a percent
bone fill value of 0.68 (68%) following the procedure. These values, along with average percent
residual defect values for male/female and left/right side alveolar clefts can be seen in Table
5.4.2. This information is also represented in box and whisker plots with the inner quartile range
displayed (Figures 5.4.2, 5.4.3, and 5.4.4).

5.5. Intra-examiner and Inter-examiner Reliability
Intraclass correlations were used to measure intra-examiner and inter-examiner values
throughout this study. The intraclass correlations-3 (ICC3) was the value analyzed. This value is
used when all subjects are rated by the same raters who are assumed to be the entire population of
raters (Shrout and Fleiss 1979). For this study, the ICC3 values ranged from 0.72 to 1.0
representing a moderate to excellent correlation between the investigators. A general guideline
for ICC values is: below 0.50 (poor), between 0.50 and 0.75 (moderate), between 0.75 and 0.90
(good), and above 0.90 (excellent).
Table 5.5.1 displays the volumes of the unilateral alveolar clefts. 20 pre-graft and postgraft CBCT images were analyzed by investigator LP and SP independently. The ICC3 value for
the inter-examiner reliability for the volumes of the cleft was 0.99 (F=167; DF=19,19; p<0.0001).
These results are represented in Table 5.5.2.
Tables 5.5.3 and 5.5.4 display the intra-examiner results for the volumes measured (by
investigators LP and SP) for the unilateral alveolar clefts. The ICC3 value for investigator LP was
1.0 (F=746; DF=19,19; p<0.0001). The ICC3 value for investigator SP was also 1.0 (F=1025;
DF=19,19; p<0.0001).
The inter-examiner reliability for the length of the canine on the cleft side can be seen in
Table 5.5.5. The ICC3 value for inter-examiner reliability length of the canine on the cleft side
was 0.72 (F=6.1; DF=19,19; p<0.001).
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Tables 5.5.6 and 5.5.7 display the intra-examiner results for the length of the canine on
the cleft side, measured by investigators LP and SP. The ICC3 value for investigator LP was 0.94
(F=34; DF=19,19; p<0.0001). The ICC3 value for investigator SP was 0.94 (F=32; DF=19,19;
p<0.0001).
Angulation, in both the coronal and sagittal sections, of the canine on the alveolar cleft
side as well as the distance of the canine on the alveolar cleft side from the occlusal plane was
only measured by investigator LP. Intra-examiner reliability was calculated for these values and
can be seen in Tables 5.5.8, 5.5.9, and 5.5.10. The ICC3 value for the angulation of the canine on
the cleft side in the coronal section was 0.95 (F=41; DF=19,19; p<0.0001). The ICC3 value for
the angulation of the canine on the cleft side in the sagittal section was 0.99 (F=180; DF=19,19;
p<0.0001). And finally, the ICC3 value for the distance of the canine on the cleft side from the
occlusal plane was 1.0 (F=458; DF=19,19; p<0.0001).
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Figure 5.2.1.1: Box & Whisker Plot for Male/Female. This plot represents the raw data of
percent residual defect by male/female. Note there are not statistics being done here but it gives
us a good idea of what we might expect. Light blue: female Dark blue: male.
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Table 5.2.1.1: Type III Tests for Fixed Effects – Male/Female. This table analyzes the percent
residual defect by male/female using a generalized linear model following a beta distribution. A
statistically significant difference was noticed in the true mean percent residual defect between
males and females.

Table 5.2.1.2: Least Squares Means – Male/Female. This table provides the least squares
means for the mean percent residual defect by male and female. Calculations were made using
the beta distribution and accounting for the variance estimated by the model.
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Figure 5.2.1.2: Least Squares Means Plot for Male/Female. This plot represents the least
squares means values in Table 5.2.1.2. The black dot corresponds to the mean estimated percent
residual defect while the error bars correspond to the lower mean and upper mean values
indicating a 95% confidence interval. Levels with different letters indicate a statistically
significant difference.
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Figure 5.2.2.1: Scatter Plot – Age of Patient at Time of Grafting. This scatter plot displays
the raw percent residual defect by age. The ages are represented as a quantitative/numeric value.
The blue line represents a linear regression line to provide an idea of whether we are seeing a
trend or not. The shaded area represents the 95% confidence interval. Note there are not
statistics being done here.
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Table 5.2.2.1: Type I Tests of Fixed Effects - Age. This table analyzes the percent residual
defect by patient age at the time of grafting by using a generalized linear model following a beta
distribution. No statistically significant relationship between the percent residual defect and the
age of the patient was noticed.

Table 5.2.2.2: Regression Coefficient Estimates for Age of the Patient. This table displays the
regression coefficient estimates for the intercept, age of the patient at the time of grafting, and
residual variance (scale). These estimates are on a model scale so will not have a direct
interpretation other than the direction of the estimated slope (negative).
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Figure 5.2.3.1: Box & Whisker Plot for Left/Right Side Alveolar Cleft. This plot represents
the raw data of percent residual defect by left/right side alveolar cleft. Note there are not
statistics being done here but it gives us a good idea of what we might expect. Light blue: left
side alveolar cleft Dark blue: right side alveolar cleft.
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Table 5.2.3.1: Type III Tests for Fixed Effects – Left/Right Side Alveolar Cleft. This table
analyzes the percent residual defect by left/right side cleft using a generalized linear model
following a beta distribution. No statistically significant difference was noticed in the true mean
percent residual defect between left and right side alveolar clefts.

Table 5.2.3.2: Least Squares Means – Left/Right Side Alveolar Cleft. This table provides the
least squares means for the mean percent residual defect by left/right side cleft. Calculations
were made using the beta distribution and accounting for the variance estimated by the model.
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Figure 5.2.3.2: Least Squares Means Plot for Left/Right Side Alveolar Cleft. This plot
represents the least squares means values in Table 5.2.3.2. The black dot corresponds to the
mean estimated percent residual defect while the error bars correspond to the lower mean and
upper mean values indicating a 95% confidence interval. Levels with different letters indicate a
statistically significant difference.
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Figure 5.3.1.1: Scatter Plot – Cleft Side Canine Root Length. This scatter plot displays the
raw percent residual defect by cleft side canine root length (as a percentage of mature length).
The blue line represents a linear regression line to provide an idea of whether we are seeing a
trend or not. The shaded area represents the 95% confidence interval. Note there are not
statistics being done here.
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Table 5.3.1.1: Type I Tests of Fixed Effects – Cleft Side Canine Root Length. This table
analyzes the percent residual defect by cleft side canine root length using a generalized linear
model following a beta distribution. No statistically significant relationship was noticed between
the percent residual defect and the canine root length on the alveolar cleft side.

Table 5.3.1.2: Regression Coefficient Estimates for Cleft Side Canine Root Length. This
table displays the regression coefficient estimates for the intercept, cleft side canine root length,
and residual variance (scale). These estimates are on a model scale so will not have a direct
interpretation other than the direction of the estimated slope (negative).
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Figure 5.3.2.1: Scatter Plot – Cleft Side Canine Angulation (Coronal). This scatter plot
displays the raw percent residual defect by cleft side canine angulation in the coronal section.
The blue line represents a linear regression line to provide an idea of whether we are seeing a
trend or not. The shaded area represents the 95% confidence interval. Note there are not
statistics being done here.
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Table 5.3.2.1: Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Coronal). This
table analyzes the percent residual defect by cleft side canine angulation in the coronal section
using a generalized linear model following a beta distribution. No statistically significant
relationship was noticed between the percent residual defect and the cleft side canine angulation
when viewed in the coronal section.

Table 5.3.2.2: Regression Coefficient Estimates for Cleft Side Canine Angulation
(Coronal). This table displays the regression coefficient estimates for the intercept, cleft side
canine angulation in the coronal section, and residual variance (scale). These estimates are on a
model scale so will not have a direct interpretation other than the direction of the estimated slope
(positive).
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Figure 5.3.3.1: Scatter Plot – Cleft Side Canine Angulation (Sagittal). This scatter plot
displays the raw percent residual defect by cleft side canine angulation in the sagittal section.
The blue line represents a linear regression line to provide an idea of whether we are seeing a
trend or not. The shaded area represents the 95% confidence interval. Note there are not
statistics being done here.
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Table 5.3.3.1: Type I Tests of Fixed Effects – Cleft Side Canine Angulation (Sagittal). This
table analyzes the percent residual defect by cleft side canine angulation in the sagittal section
using a generalized linear model following a beta distribution. No statistically significant
relationship was noticed between the percent residual defect and the cleft side canine angulation
when viewed in the sagittal section.

Table 5.3.3.2: Regression Coefficient Estimates for Cleft Side Canine Angulation (Sagittal).
This table displays the regression coefficient estimates for the intercept, cleft side canine
angulation in the sagittal section, and residual variance (scale). These estimates are on a model
scale so will not have a direct interpretation other than the direction of the estimated slope
(negative).
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Figure 5.3.4.1: Scatter Plot – Cleft Side Canine Distance from Occlusal Plane. This scatter
plot displays the raw percent residual defect by cleft side canine distance from occlusal plane.
The blue line represents a linear regression line to provide an idea of whether we are seeing a
trend or not. The shaded area represents the 95% confidence interval. Note there are not
statistics being done here.
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Table 5.3.4.1: Type I Tests of Fixed Effects – Cleft Side Canine Distance from Occlusal
Plane. This table analyzes the percent residual defect by cleft side canine distance from the
occlusal plane using a generalized linear model following a beta distribution. No statistically
significant relationship was noticed between the percent residual defect and the cleft side canine
distance.

Table 5.3.4.2: Regression Coefficient Estimates for Cleft Side Canine Distance from
Occlusal Plane. This table displays the regression coefficient estimates for the intercept, cleft
side canine distance from occlusal plane, and residual variance (scale). These estimates are on a
model scale so will not have a direct interpretation other than the direction of the estimated slope
(positive).
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Table 5.4.1: Overall Volumetric Values for Unilateral Clefts. This table displays the overall
volumetric values in mm3 for the unilateral clefts. A total of 23 patients were included for the
statistical analysis summary. Pre-graft and 6-month post-graft CBCT images were evaluated.
The table also includes volumetric values for left/right alveolar cleft and male/female variables
within our sample.

Figure 5.4.1: Overall Volumetric Values for Unilateral Clefts. This box & whisker plots
display the overall volumetric values in mm3 for the unilateral clefts. A total of 23 patients were
included for the statistical analysis summary. Pre-graft (left) and 6-month post-graft (right)
CBCT images were evaluated. Black horizontal line: 50th percentile (median) Blue box: inner
quartile range (25th -75th percentile).
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Table 5.4.2: Percent Residual Defect Using rhBMP-2. This table shows the overall percent
residual defect measured on the 6-month post-graft CBCT images for the 23 patients in our
study. A mean value of 0.32 (SD = 0.22) represents a 32% residual defect in the post-graft scan
meaning an overall bone fill of 68% using rhBMP-2 for secondary grafting of unilateral alveolar
clefts. The table also includes the breakdown of percent residual defect for left/right alveolar
cleft and male/female variables within our sample.

Figure 5.4.2: Percent Residual Defect Using rhBMP-2. This box & whisker plot displays the
overall percent residual defect using rhBMP-2. A total of 23 patients were included for the
statistical analysis summary. Black horizontal line: 50th percentile (median) Blue box: inner
quartile range (25th -75th percentile).
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Figure 5.4.3: Percent Residual Defect Using rhBMP-2; Male/Female. This box & whisker
plot displays the overall percent residual defect using rhBMP-2 for male/female patients. 11
males (right) and 12 females (left) were included for the statistical analysis summary. Black
horizontal lines: 50th percentile (median) Blue boxes: inner quartile range (25th -75th percentile).
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Figure 5.4.4: Percent Residual Defect Using rhBMP-2; Left/Right Alveolar Cleft. This box
& whisker plot displays the overall percent residual defect using rhBMP-2 for left/right alveolar
clefts. 13 left alveolar clefts (left) and 10 right alveolar clefts (right) were included for the
statistical analysis summary. Black horizontal lines: 50th percentile (median) Blue boxes: inner
quartile range (25th -75th percentile).
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Table 5.5.1: Inter-examiner Reliability Raw Data. This table shows the volumetric values in
mm3 for the unilateral alveolar cleft on 10 patients included in this study. The 20 CBCT images
(both pre-graft and post-graft) were measured independently by investigators LP and SP and
submitted for statistical analysis.

Table 5.5.2: Inter-examiner ICC3 Results. This table displays the inter-examiner intraclass
correlation coefficients (ICC3) for unilateral cleft volume measured by investigators LP and SP.
The results are based on 20 independently measured CBCT images. An ICC3 value of 0.99
represents excellent correlation.
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Table 5.5.3: Intra-examiner ICC3 Results for Cleft Volume; Investigator LP. This table
displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft volume. The
results are based on initial 20 CBCT images measured by investigator LP. After at least 2 weeks,
these same 10 patients (20 CBCT images) were analyzed by investigator LP. An ICC3 value of
1.0 represents excellent correlation.

Table 5.5.4: Intra-examiner ICC3 Results for Cleft Volume; Investigator SP. This table
displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft volume. The
results are based on initial 20 CBCT images measured by investigator SP. After at least 2 weeks,
these same 10 patients (20 CBCT images) were analyzed by investigator SP. An ICC3 value of
1.0 represents excellent correlation.

Table 5.5.5: Inter-examiner ICC3 Results for Cleft Side Canine Length. This table displays
the inter-examiner intraclass correlation coefficients (ICC3) for cleft side canine length
measured by investigators LP and SP. The results are based on 20 independently measured
CBCT images. An ICC3 value of 0.72 is on the higher end of moderate correlation.
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Table 5.5.6: Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator LP.
This table displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft side
canine length. The results are based on initial 20 CBCT images measured by investigator LP.
After at least 2 weeks, these same 10 patients (20 CBCT images) were analyzed by investigator
LP. An ICC3 value of 0.94 represents excellent correlation.

Table 5.5.7: Intra-examiner ICC3 Results for Cleft Side Canine Length; Investigator SP.
This table displays the intra-examiner intraclass correlation coefficients (ICC3) for cleft side
canine length. The results are based on initial 20 CBCT images measured by investigator SP.
After at least 2 weeks, these same 10 patients (20 CBCT images) were analyzed by investigator
SP. An ICC3 value of 0.94 represents excellent correlation.

Table 5.5.8: Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Coronal);
Investigator LP. This table displays the intra-examiner intraclass correlation coefficients (ICC3)
for cleft side canine angulation in the coronal section. The results are based on initial 20 CBCT
images measured by investigator LP. After at least 2 weeks, these same 10 patients (20 CBCT
images) were analyzed by investigator LP. An ICC3 value of 0.95 represents excellent
correlation.
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Table 5.5.9: Intra-examiner ICC3 Results for Cleft Side Canine Angulation (Sagittal);
Investigator LP. This table displays the intra-examiner intraclass correlation coefficients (ICC3)
for cleft side canine angulation in the sagittal section. The results are based on initial 20 CBCT
images measured by investigator LP. After at least 2 weeks, these same 10 patients (20 CBCT
images) were analyzed by investigator LP. An ICC3 value of 0.99 represents excellent
correlation.

Table 5.5.10: Intra-examiner ICC3 Results for Cleft Side Canine Distance from Occlusal
Plane; Investigator LP. This table displays the intra-examiner intraclass correlation coefficients
(ICC3) for cleft side canine distance from the occlusal plane. The results are based on initial 20
CBCT images measured by investigator LP. After at least 2 weeks, these same 10 patients (20
CBCT images) were analyzed by investigator LP. An ICC3 value of 1.0 represents excellent
correlation.
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CHAPTER 6: DISCUSSION
6.1. Demographic Variables and Their Effects on Outcomes
6.1.1. Gender
There was a statistically significant difference in the volume of the residual defect
between males and females (F=10.63; DF=1,21; p=0.0037) in our study. The estimated mean
percent residual defect for females was 20.52% (Standard Error = 4.2%) and we are 95%
confident the true mean percent residual defect for females is between 13.1% and 30.68%. The
estimated mean percent residual defect for males was 44.20% (Standard Error = 5.7%) and we are
95% confident the true mean percent residual defect for males is between 32.93% and 56.1%
(Figure 5.2.1.2). These values were compared to and noticeably different than a study by Saruhan
and Ertas in 2017. This study used anterior iliac crest as the grafting material for unilateral and
bilateral alveolar clefts. They concluded a mean bone fill of 68.23% +/- 9.43% for females and
63.09% +/- 10.72% for males. There was no statistically significant difference found between
males and females in this study (Saruhan and Ertaş 2017).
It is not likely that a different grafting material, such as rhBMP-2, would cause gender
differences to have an effect on alveolar cleft graft outcomes.

6.1.2. Age of the Patient at the Time of Grafting
There was no statistically significant relationship between the percent residual defect and
the age of the patient at the time of grafting (F=0.00; DF=1,21; p=0.97). The effect of age on the
outcomes of the alveolar bone grafts was calculated as a quantitative/numeric value as well as a
qualitative/categorical value. The quantitative/numeric values were reported in our study. Since
the data was on the model scale (non-normal data distribution), a direct interpretation could not
be determined. However, the direction of the slope value provided insight on how age of the
patient at the time of grafting could affect the outcome. The slope value for age and percent
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residual defect was -0.00466 and can be seen in Table 5.2.2.2. This negative slope relationship
suggests that as age increased within our inclusion criteria range, the percent residual defect
decreased and hence bone fill increased.
A systematic review of the literature was completed in 2018 by Kaura et al. to understand
how age effects the outcomes of alveolar grafts. When looking at the studies that used
chronological age as the determining factor, the authors found the chronological age for alveolar
grafting ranged from 10-14 with an average of 10 years old. Our results are similar to the
conclusion of this 2018 study; bone grafting completed at an earlier chronologic age did not show
better outcomes (Kaura et al. 2018).
6.1.3. Side of the Alveolar Cleft
There was no statistically significant difference in the true mean percent residual defect
between left and right side alveolar clefts (F=0.6; DF=1,21; p=0.45). The estimated mean percent
residual defect for the left side alveolar cleft was 34.46% (Standard Error = 5.7%) and we are
95% confident the true mean percent residual defect for left side alveolar cleft is between 23.67%
and 47.12%. The estimated mean percent residual defect for the right side alveolar cleft was
28.06% (Standard Error = 6.0%) and we are 95% confident the true mean percent residual defect
for right side alveolar cleft is between 17.31% and 42.08% (Figure 5.2.3.2).
There is very limited research available on whether the affected side of the patient with
unilateral alveolar cleft has an effect on the graft success rate. Our study analyzed this
comparison and found no statistically significant difference.

6.2. Linear Values and Their Effects on Outcomes
6.2.1. Cleft Side Canine Root Length
There was no statistically significant relationship between the percent residual defect and
length of the canine on the alveolar cleft side (F=0.61; DF=1,21; p=0.44). Since the data was on
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the model scale (non-normal data distribution), a direct interpretation could not be determined.
However, the direction of the slope value provided insight on how the cleft side canine root
length could affect the outcome. The slope value for cleft side canine root length was -0.9491 and
can be seen in Table 5.3.1.2. This negative slope relationship suggests that as the length of the
canine on the cleft side increased, the percent residual defect decreased and hence bone fill
increased.
The overall consensus is that outcomes are better when secondary alveolar bone grafts
are completed based on the dental age or root development of the canine on the cleft side. The
ideal time for alveolar grafting procedures to be completed is before the eruption of the cleft side
canine and when the root of this tooth has one-half to two-thirds of its root development
completed (Bergland et al. 1986; Boyne and Sands 1972). In our study, we could not demonstrate
a statistically significant difference when analyzing the length of the canine on the cleft side.

6.2.2. Cleft Side Canine Angulation; Coronal and Sagittal Sections
There was no statistically significant relationship between the percent residual defect and
the angulation of the canine on the cleft side in neither the coronal section (F=2.15; DF=1,21;
p=0.15) nor the sagittal section (F=0.13; DF=1,21; p=0.72). Since the data was on the model
scale (non-normal data distribution), a direct interpretation could not be determined. However,
the direction of the slope value provided insight on how the angulation of the canine on the cleft
side in both the coronal and sagittal sections could affect the outcome. The slope value for the
cleft side canine angulation in the coronal section was 0.03561 and can be seen in Table 5.3.2.2.
This positive slope relationship suggests that as the angulation, in the coronal section, of the
canine on the cleft side increased, the percent residual defect also increased and hence bone fill
decreased. The slope value for the angulation of the canine on the cleft side in the sagittal section
was -0.00592 and can be seen in Table 5.3.3.2. This negative slope relationship suggests that as
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the angulation, in the sagittal section, of the canine on the cleft side increased, the percent
residual defect decreased and hence bone fill increased.
Most of the previous studies relating to this variable focuses on the natural eruption of the
canine following the secondary alveolar grafting procedure. Vellone et al. studied the effects of
secondary alveolar bone grafting on canine eruption. The authors concluded there was no proof
that inclination of the canine influenced the eruption before and after the grafting procedure. They
did however, conclude secondary alveolar bone grafts significantly affected the natural eruption
process of the canine (Vellone et al. 2017). Although this study did not draw a correlation
between inclination of the canine and its eruption process, we wanted to understand the effect of
canine inclination on overall success rates for unilateral alveolar grafts. It appears that the more
upright the permanent canine on the cleft side is, in both sections, at the time of grafting, the
higher percentage of bone fill recorded. Still, no statistically significant difference was noticed.

6.2.3. Cleft Side Canine Distance from the Occlusal Plane
There was no statistically significant relationship between the percent residual defect and
the distance of the canine on the alveolar cleft side from the occlusal plane (F=0.11; DF=1,21;
p=0.74). Since the data was on the model scale (non-normal data distribution), a direct
interpretation could not be determined. However, the direction of the slope value provided insight
on how the distance of the canine on the cleft side from the occlusal plane could affect the
outcome. The slope value for the distance of the canine on the cleft side from the occlusal plane
was 0.01404 and can be seen in Table 5.3.4.2. This positive slope relationship suggests that as
this distance from the occlusal plane increased, the percent residual defect also increased and
hence bone fill decreased.
Our results are similar to those of Upadya et al. This study concluded that the position of
the canine on the cleft side, inclination, and distance from the cleft itself, did not have an effect
on the success rates of secondary alveolar grafts (Upadya et al. 2013). However, it is still
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important to consider the positive slope relationship. It seems as though secondary alveolar grafts
can indeed be completed too early in the patients’ lives.

6.3. Volumetric Values and Percent Residual Defect
Out of the 24 patients analyzed, one patient was excluded during the statistical analysis
with a failed alveolar graft. Data from 23 patients were evaluated for success rates. rhBMP-2 was
used for all of the unilateral alveolar cleft grafting procedures completed at the University of
Nebraska Medical Center Oral and Maxillofacial Surgery Center. The mean volume of the pregraft unilateral cleft was 1026.97mm3 (SD = 390.11) and the mean volume of the post-graft
unilateral cleft was 333.48mm3 (SD = 250.94). These volumes can be seen in Table 5.4.1. The
overall average percent residual defect at 6-months post-graft was 0.32 (32%) with a standard
deviation of 0.32 (32%). This corresponds to an overall average bone fill of 0.68 (68%) with a
standard deviation of 0.22 (22%). These values can be seen in Table 5.4.2.
Our results on the outcomes of secondary grafting unilateral alveolar clefts seem to be
slightly lower than previous literature reports. The study by Francis et al. used occlusal
radiographs to compare rhBMP-2 and iliac crest as grafting materials. The success rates were
97.2% and 84.2% for rhBMP-2 and iliac crest respectively (Francis et al. 2013). The difference in
understanding the pyramid-shaped cleft defect between occlusal radiographs and CBCT images
may lead to this difference in results. The 2-dimensional images may overestimate the success
rates. Linderup et al. concluded a pre-graft cleft volume of 934mm3 with an average percentage
bone fill of 87%. This study used mandibular symphyseal bone as the grafting material of choice
and analyzed the outcomes with CBCT images (Linderup et al. 2016). Oberoi et al. studied the
outcomes of secondary bone grafts of alveolar clefts using CBCT images and found an average
bone fill of 84% (Oberoi et al. 2009). And finally, a study conducted by Herford et al. specifically
focused on the outcomes of repairing the premaxillary cleft using rhBMP-2 and evaluated with
CT images found a mean bone fill of 71.7% at 4-months post-graft (Herford et al. 2007).
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All of the previous studies mentioned have either used 2-dimensional radiographs to
assess a 3-dimensional defect, included unilateral and bilateral alveolar clefts, and/or used a
different material to complete the graft procedure. It is important to understand our results using
rhBMP-2 to graft unilateral alveolar clefts and evaluating the outcomes using CBCT images. Our
results on percent residual defect/percent bone fill are similar to the results reported by Herford et
al., which closely resembles our study parameters.

6.4. Limitations of the Study
6.4.1. Radiographic Limitations
A limitation of this study is in relation to the method of radiographic capturing, CBCT
images. It is well known that CBCT is a reliable tool for orthodontic treatment as well as research
modalities (Kapila et al. 2011). However, problems arise when attempting to accurately measure
hard tissues, such as the borders of the alveolar cleft defect (Molen 2010). The technology used in
this study offers a diagnostic value of 0.2 mm voxels. Theoretically, this means we could measure
up to 0.2 mm and be fairly confident at that level. However, previous literature demonstrates that
the actual spatial resolution is worse than the true voxel size with factors such as noise and
artifact negatively affect the quality of the image (Molen 2010). The spatial resolution used
within this study is not entirely known, but past studies of older CBCT images correlated a 0.3
mm voxel size to a spatial resolution around 0.6 mm (Brullmann and Schulze 2015). When trying
to understand the amount of percent residual defect or bone fill in the alveolar cleft area, it is
important to understand the actual magnitudes of change and assess if they accurately can be
measured or assessed based off the voxel size, or more importantly, the true spatial resolution.
CBCT image quality was also a limitation that was noticed during data collection.
Medical records and pre-graft/post-graft CBCT images of all patients who received secondary
alveolar bone grafts between June 1, 2014 and January 1, 2020 were retrieved. Of the 55 patients
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that met our initial criteria, only 24 patients had pre-graft and post-graft CBCT images that were
free of noise or artifact.

6.4.2. Software Limitations
The ITK-SNAP 3.8.0 software used for segmentation introduced other limitations to our
study. The degree of image quality and pixelation provided by the software determines the
accuracy of measurements. This limitation was observed during the volumetric data gathering
process for our unilateral cleft defects. Volumetric segmentation introduced challenges in
obtaining a clear distinction between similar grey scale pixels such as those of alveolar bone and
grafting material. To overcome these inaccuracies, the volumetric thresholding parameters were
set very similar, within ITK-SNAP 3.8.0, when measuring the same patient. Additionally, strict
semi-automatic and manual segmentation parameters were developed between the two
investigators (LP and SP).
The anterior and posterior borders of the alveolar cleft were determined by manual
segmentation. The contralateral normal anatomical bone structure was mimicked to define these
borders. The two investigators (LP and SP) were standardized and calibrated before segmentation
to eliminate as much subjectivity as possible. Intraclass correlations for inter- and intra-examiner
reliability were calculated to determine the accuracy of our measurements. However, this is
inevitably a limitation within segmentation studies and has to be mentioned.
Lastly, percent residual defect was reported as our outcome measure to help eliminate the
variability within the reported volumetric ranges. This limitation will exist in segmentation
research studies until new software updates become available to provide more accurate
delineations between grey values that are very similar.
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6.4.3. Sample Limitations
Drawing a correlation between our 23 patients included for statistical analysis to the true
population is another limitation. Our patients were only sampled from one location, University of
Nebraska Medical Center Oral and Maxillofacial Surgery Center. The demographics may not
represent the entire population.
Other sample limitations were noted within our study. First, narrowing down patients for
our study was dependent on the notes, CBCT images, and histories provided by the oral surgeon
at the location mentioned above. We tried to minimize the amount of variability in patient
selection by defining specific inclusion and exclusion criteria. Next, true randomization is
impossible with the nature of retrospective studies. We attempted to minimize the potential bias
during data collection and measurements. Patient records were collected with the specified
inclusion and exclusion criteria to reduce bias. Additionally, the 23 patients measured in this
study were randomly split up into two groups for the investigators (LP and SP) to segment within
ITK-SNAP 3.8.0.
6.5. Conclusions
The present study indicates a statistically significant difference in the percent residual
defect exists between males and females. This was the only variable analyzed in this study that
demonstrated a significant difference. There was not enough evidence to conclude there is a
significant difference in the percent residual defect between left and right side alveolar clefts.
Additionally, our data did not demonstrate a significant relationship between the percent residual
defect and the following variables: age of the patient at the time of surgery, cleft side canine root
length, cleft side canine angulation in the coronal section, cleft side canine angulation in the
sagittal section, or cleft side canine distance from the occlusal plane.
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Correlation was determined for several of the variables studied. Although not statistically
significant, these correlates could provide insight into the relationship that exists between the
outcomes of secondary alveolar bone grafts and the variables studied.
The present study also suggests that rhBMP-2 could be an alternative grafting material to
anterior iliac crest. With percent residual defect values of 32% and bone fill values of 68% six
months following surgery, rhBMP-2 seems to demonstrate similar results compared to other
grafting materials. This could allow patients to choose this alternate material to eliminate the
complications associated with harvesting anterior iliac crest bone while still achieving successful
outcomes.
6.6. Future Research
Future research for this area could address some of the limitations of the present study.
The CBCT imaging parameters could be improved to more accurately provide us with the data
necessary for research. Spatial resolution and volume rendering software need improvement to
allow for more efficient segmentation and to obtain more accurate volumetric data for analysis.
Manual segmentation is currently needed during volumetric measurements to distinguish between
similar density areas such as alveolar bone and grafting material. The method of calculating a
percent residual defect has allowed projects to minimize this effect, but intensive labor is required
for manual segmentation. Superior volume segmentation software exists, however most have
algorithms that are not verified or standardized. Future studies that use segmentation software that
clearly and accurately auto-segments the area of interest would allow for more accurate
volumetric parameters and assessments while eliminating the need for tedious manual
segmentation.
Our study was retrospective in design with well-defined inclusion and exclusion criteria.
Future prospective studies in which records are taken during diagnosis and treatment could
provide valuable information. Pre-treatment risk factors could be accounted for if the treatment
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protocols were standardized and clinical records were maintained throughout treatment.
Additionally, patient demographics and clinical information such as unilateral or bilateral alveolar
cleft, age of the patient, and side of the alveolar cleft could be assessed for treatment
standardization.
Finally, a prospective study to compare the outcomes of rhBMP-2 and anterior iliac crest
for secondary alveolar bone grafts in unilateral alveolar cleft patients would provide more insight
into the effectiveness of this alternative material. A larger sample size, increased variety of
patient demographics, and including multiple surgical sites/surgeons may lead to more reliable
results when comparing these two grafting materials in a prospective study.
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